CN100515381C - Drug solution filling plastic ampoule and production method therefor - Google Patents
Drug solution filling plastic ampoule and production method therefor Download PDFInfo
- Publication number
- CN100515381C CN100515381C CNB2004800106848A CN200480010684A CN100515381C CN 100515381 C CN100515381 C CN 100515381C CN B2004800106848 A CNB2004800106848 A CN B2004800106848A CN 200480010684 A CN200480010684 A CN 200480010684A CN 100515381 C CN100515381 C CN 100515381C
- Authority
- CN
- China
- Prior art keywords
- layer
- ampoule
- medicinal liquid
- plastic ampoule
- filling
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003708 ampul Substances 0.000 title claims abstract description 231
- 229920003023 plastic Polymers 0.000 title claims abstract description 149
- 239000004033 plastic Substances 0.000 title claims abstract description 149
- 238000011049 filling Methods 0.000 title claims abstract description 117
- 239000003814 drug Substances 0.000 title claims abstract description 91
- 229940079593 drug Drugs 0.000 title claims abstract description 22
- 238000004519 manufacturing process Methods 0.000 title claims description 25
- 239000010410 layer Substances 0.000 claims abstract description 257
- 238000010521 absorption reaction Methods 0.000 claims abstract description 45
- 238000000034 method Methods 0.000 claims abstract description 27
- 239000002346 layers by function Substances 0.000 claims abstract description 23
- 238000001179 sorption measurement Methods 0.000 claims abstract 4
- 239000007788 liquid Substances 0.000 claims description 135
- 229920000098 polyolefin Polymers 0.000 claims description 47
- 239000007789 gas Substances 0.000 claims description 36
- 238000007789 sealing Methods 0.000 claims description 35
- 239000002250 absorbent Substances 0.000 claims description 27
- 230000002745 absorbent Effects 0.000 claims description 27
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 20
- 229910052760 oxygen Inorganic materials 0.000 claims description 20
- 239000001301 oxygen Substances 0.000 claims description 20
- 239000003086 colorant Substances 0.000 claims description 16
- 230000006870 function Effects 0.000 claims description 14
- 150000005846 sugar alcohols Polymers 0.000 claims description 13
- 229920000728 polyester Polymers 0.000 claims description 9
- 239000004760 aramid Substances 0.000 claims description 7
- 229920003235 aromatic polyamide Polymers 0.000 claims description 7
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 claims description 5
- 150000001336 alkenes Chemical class 0.000 claims description 4
- 125000003367 polycyclic group Polymers 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 3
- 238000007664 blowing Methods 0.000 abstract description 45
- 230000004888 barrier function Effects 0.000 abstract description 35
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 10
- 230000005540 biological transmission Effects 0.000 abstract 4
- 239000008155 medical solution Substances 0.000 abstract 3
- 230000002265 prevention Effects 0.000 abstract 1
- 229920003050 poly-cycloolefin Polymers 0.000 description 62
- 238000002360 preparation method Methods 0.000 description 36
- -1 polyethylene Polymers 0.000 description 27
- 239000004698 Polyethylene Substances 0.000 description 18
- 229920000573 polyethylene Polymers 0.000 description 18
- 239000000463 material Substances 0.000 description 17
- 229920000642 polymer Polymers 0.000 description 17
- 230000009477 glass transition Effects 0.000 description 16
- 239000004743 Polypropylene Substances 0.000 description 15
- 239000007864 aqueous solution Substances 0.000 description 14
- 102000015347 COP1 Human genes 0.000 description 12
- 108060001826 COP1 Proteins 0.000 description 12
- SNIOPGDIGTZGOP-UHFFFAOYSA-N Nitroglycerin Chemical compound [O-][N+](=O)OCC(O[N+]([O-])=O)CO[N+]([O-])=O SNIOPGDIGTZGOP-UHFFFAOYSA-N 0.000 description 12
- 229960003711 glyceryl trinitrate Drugs 0.000 description 12
- 239000000203 mixture Substances 0.000 description 12
- 229920001577 copolymer Polymers 0.000 description 11
- 229920005989 resin Polymers 0.000 description 11
- 239000011347 resin Substances 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- 230000015572 biosynthetic process Effects 0.000 description 10
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 10
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 9
- 239000005977 Ethylene Substances 0.000 description 9
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 9
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 9
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 238000005984 hydrogenation reaction Methods 0.000 description 8
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 7
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 7
- 229930003471 Vitamin B2 Natural products 0.000 description 7
- 239000012860 organic pigment Substances 0.000 description 7
- 229920001155 polypropylene Polymers 0.000 description 7
- 229960002477 riboflavin Drugs 0.000 description 7
- 235000019164 vitamin B2 Nutrition 0.000 description 7
- 239000011716 vitamin B2 Substances 0.000 description 7
- 238000000071 blow moulding Methods 0.000 description 6
- ZSWFCLXCOIISFI-UHFFFAOYSA-N cyclopentadiene Chemical compound C1C=CC=C1 ZSWFCLXCOIISFI-UHFFFAOYSA-N 0.000 description 6
- 230000005764 inhibitory process Effects 0.000 description 6
- 230000003647 oxidation Effects 0.000 description 6
- 238000007254 oxidation reaction Methods 0.000 description 6
- 238000007151 ring opening polymerisation reaction Methods 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 5
- 238000001782 photodegradation Methods 0.000 description 5
- 239000000049 pigment Substances 0.000 description 5
- 230000003252 repetitive effect Effects 0.000 description 5
- 238000007493 shaping process Methods 0.000 description 5
- 235000010265 sodium sulphite Nutrition 0.000 description 5
- 101100282455 Arabidopsis thaliana AMP1 gene Proteins 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 101100218464 Haloarcula sp. (strain arg-2 / Andes heights) cop2 gene Proteins 0.000 description 4
- 239000004952 Polyamide Substances 0.000 description 4
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 239000005038 ethylene vinyl acetate Substances 0.000 description 4
- 229920001684 low density polyethylene Polymers 0.000 description 4
- 239000004702 low-density polyethylene Substances 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 4
- 229920002647 polyamide Polymers 0.000 description 4
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 4
- 229940001482 sodium sulfite Drugs 0.000 description 4
- 101100285389 Arabidopsis thaliana HLS1 gene Proteins 0.000 description 3
- 101150030345 COP3 gene Proteins 0.000 description 3
- 229920000219 Ethylene vinyl alcohol Polymers 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 230000000857 drug effect Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 229920001903 high density polyethylene Polymers 0.000 description 3
- 239000004700 high-density polyethylene Substances 0.000 description 3
- IVSZLXZYQVIEFR-UHFFFAOYSA-N m-xylene Chemical group CC1=CC=CC(C)=C1 IVSZLXZYQVIEFR-UHFFFAOYSA-N 0.000 description 3
- 239000000155 melt Substances 0.000 description 3
- 239000005020 polyethylene terephthalate Substances 0.000 description 3
- 229920000139 polyethylene terephthalate Polymers 0.000 description 3
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 3
- 239000002356 single layer Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- AFFLGGQVNFXPEV-UHFFFAOYSA-N 1-decene Chemical compound CCCCCCCCC=C AFFLGGQVNFXPEV-UHFFFAOYSA-N 0.000 description 2
- LIKMAJRDDDTEIG-UHFFFAOYSA-N 1-hexene Chemical compound CCCCC=C LIKMAJRDDDTEIG-UHFFFAOYSA-N 0.000 description 2
- KWKAKUADMBZCLK-UHFFFAOYSA-N 1-octene Chemical compound CCCCCCC=C KWKAKUADMBZCLK-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- WSSSPWUEQFSQQG-UHFFFAOYSA-N 4-methyl-1-pentene Chemical compound CC(C)CC=C WSSSPWUEQFSQQG-UHFFFAOYSA-N 0.000 description 2
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- 241001597008 Nomeidae Species 0.000 description 2
- 229920002292 Nylon 6 Polymers 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- 229910021536 Zeolite Inorganic materials 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 239000001361 adipic acid Substances 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 2
- DDPFHDCZUJFNAT-PZPWKVFESA-N chembl2104402 Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1N=CNC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CCCCCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 DDPFHDCZUJFNAT-PZPWKVFESA-N 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000009833 condensation Methods 0.000 description 2
- 230000005494 condensation Effects 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 150000001925 cycloalkenes Chemical class 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 229960000756 elcatonin Drugs 0.000 description 2
- 108700032313 elcatonin Proteins 0.000 description 2
- 125000004185 ester group Chemical group 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- FKRCODPIKNYEAC-UHFFFAOYSA-N ethyl propionate Chemical compound CCOC(=O)CC FKRCODPIKNYEAC-UHFFFAOYSA-N 0.000 description 2
- 230000004927 fusion Effects 0.000 description 2
- 238000005227 gel permeation chromatography Methods 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- 150000002367 halogens Chemical class 0.000 description 2
- LNEPOXFFQSENCJ-UHFFFAOYSA-N haloperidol Chemical compound C1CC(O)(C=2C=CC(Cl)=CC=2)CCN1CCCC(=O)C1=CC=C(F)C=C1 LNEPOXFFQSENCJ-UHFFFAOYSA-N 0.000 description 2
- 229920001519 homopolymer Polymers 0.000 description 2
- 150000002430 hydrocarbons Chemical group 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 150000002431 hydrogen Chemical class 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 2
- 239000011976 maleic acid Substances 0.000 description 2
- 229920001179 medium density polyethylene Polymers 0.000 description 2
- 239000004701 medium-density polyethylene Substances 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 238000000465 moulding Methods 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N o-dicarboxybenzene Natural products OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 238000010525 oxidative degradation reaction Methods 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 2
- 239000004014 plasticizer Substances 0.000 description 2
- 229920001707 polybutylene terephthalate Polymers 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 229940079877 pyrogallol Drugs 0.000 description 2
- 238000007363 ring formation reaction Methods 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 238000013517 stratification Methods 0.000 description 2
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 2
- 239000010409 thin film Substances 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 239000010457 zeolite Substances 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- 229930007845 β-thujaplicin Natural products 0.000 description 2
- 229920001651 Cyanoacrylate Polymers 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- HECLRDQVFMWTQS-UHFFFAOYSA-N Dicyclopentadiene Chemical class C1C2C3CC=CC3C1C=C2 HECLRDQVFMWTQS-UHFFFAOYSA-N 0.000 description 1
- BALXUFOVQVENIU-GNAZCLTHSA-N Ephedrine hydrochloride Chemical compound Cl.CN[C@@H](C)[C@H](O)C1=CC=CC=C1 BALXUFOVQVENIU-GNAZCLTHSA-N 0.000 description 1
- 101150015738 Fev gene Proteins 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 102100037681 Protein FEV Human genes 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- HOBWAPHTEJGALG-JKCMADFCSA-N [(1r,5s)-8-methyl-8-azoniabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate;sulfate Chemical compound [O-]S([O-])(=O)=O.C([C@H]1CC[C@@H](C2)[NH+]1C)C2OC(=O)C(CO)C1=CC=CC=C1.C([C@H]1CC[C@@H](C2)[NH+]1C)C2OC(=O)C(CO)C1=CC=CC=C1 HOBWAPHTEJGALG-JKCMADFCSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004840 adhesive resin Substances 0.000 description 1
- 229920006223 adhesive resin Polymers 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 229960002028 atropine sulfate Drugs 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- 239000012964 benzotriazole Substances 0.000 description 1
- 150000001565 benzotriazoles Chemical class 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- OJGDCBLYJGHCIH-UHFFFAOYSA-N bromhexine Chemical compound C1CCCCC1N(C)CC1=CC(Br)=CC(Br)=C1N OJGDCBLYJGHCIH-UHFFFAOYSA-N 0.000 description 1
- 229960003870 bromhexine Drugs 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- NLCKLZIHJQEMCU-UHFFFAOYSA-N cyano prop-2-enoate Chemical class C=CC(=O)OC#N NLCKLZIHJQEMCU-UHFFFAOYSA-N 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- FWZTTZUKDVJDCM-CEJAUHOTSA-M disodium;(2r,3r,4s,5s,6r)-2-[(2s,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol;iron(3+);oxygen(2-);hydroxide;trihydrate Chemical compound O.O.O.[OH-].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[Na+].[Na+].[Fe+3].[Fe+3].[Fe+3].[Fe+3].[Fe+3].O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 FWZTTZUKDVJDCM-CEJAUHOTSA-M 0.000 description 1
- MCPKSFINULVDNX-UHFFFAOYSA-N drometrizole Chemical compound CC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 MCPKSFINULVDNX-UHFFFAOYSA-N 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960002534 ephedrine hydrochloride Drugs 0.000 description 1
- VXNZUUAINFGPBY-UHFFFAOYSA-N ethyl ethylene Natural products CCC=C VXNZUUAINFGPBY-UHFFFAOYSA-N 0.000 description 1
- 229920006242 ethylene acrylic acid copolymer Polymers 0.000 description 1
- 239000004715 ethylene vinyl alcohol Substances 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 1
- 235000003969 glutathione Nutrition 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 229960003878 haloperidol Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- 239000011229 interlayer Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000002650 laminated plastic Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- TVMXDCGIABBOFY-UHFFFAOYSA-N n-Octanol Natural products CCCCCCCC TVMXDCGIABBOFY-UHFFFAOYSA-N 0.000 description 1
- ALWKGYPQUAPLQC-UHFFFAOYSA-N neostigmine Chemical compound CN(C)C(=O)OC1=CC=CC([N+](C)(C)C)=C1 ALWKGYPQUAPLQC-UHFFFAOYSA-N 0.000 description 1
- 229960002362 neostigmine Drugs 0.000 description 1
- 229920006113 non-polar polymer Polymers 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- YWAKXRMUMFPDSH-UHFFFAOYSA-N pentene Chemical group CCCC=C YWAKXRMUMFPDSH-UHFFFAOYSA-N 0.000 description 1
- IEQIEDJGQAUEQZ-UHFFFAOYSA-N phthalocyanine Chemical compound N1C(N=C2C3=CC=CC=C3C(N=C3C4=CC=CC=C4C(=N4)N3)=N2)=C(C=CC=C2)C2=C1N=C1C2=CC=CC=C2C4=N1 IEQIEDJGQAUEQZ-UHFFFAOYSA-N 0.000 description 1
- 229920002239 polyacrylonitrile Polymers 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000007142 ring opening reaction Methods 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 229940057531 saccharated iron oxide Drugs 0.000 description 1
- 238000007127 saponification reaction Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229920003051 synthetic elastomer Polymers 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Abstract
The invention provides a plastic ampoule for filling medical solution, which has barrier property function for gas, water vapour and luminous ray and the prevention function for drug transmission, absorption and adsorption and a preparing method thereof. The plastic ampoule 10 of the invention for filling the medical solution comprises a container body 11, a fusing part 13 for closing an opening part 12, and a holding part 14 which is connected to the plastic ampoule and used for twisting off. The plastic ampoule 10 is formed by a parison provided with more than two layers, wherein, at least one layer is a functional layer with at least one characteristic selected from gas permeation resistance, water vapour transmission resistance, ray transmission resistance, drug transmission resistance, and drug absorption and adsorption resistance. Namely, the parison is extruded from a multilayer blowing mould, and is clamped by a separable die on the lower part to form the container body 11, the parison is filled with the medical solution 15, the opening part 12 is clamped by the separable die on the upper part, and the fusing part 13 and the holding part 14 are formed, thereby obtaining the product of the invention.
Description
Technical field
The present invention relates to a kind of plastic ampoule that is pre-charged with medicinal liquid.In more detail, relate to a kind of gas, light or medicine beyond the water vapour, water vapour (medicament, medicinal liquid, their solvent etc.) of can preventing and immerse or leach to ampoule is outside to ampoule is inner, the medicament that perhaps can prevent from ampoule, to hold, medicinal liquid, solvent etc. to the ampoule inner surface absorb, the plastic ampoule and the manufacture method thereof of the filling medicinal liquid of absorption.
Background technology
At present, the ampoule of receiving medical liquids is to use glass mostly.But glass ampule causes the dissolved problem of alkaline thin slice at the medicinal liquid pH Gao Shihui that holds.And the fragment of the danger of problem that finger is hurt easily when the ampoule of Kaifeng and ampoule breakage, generation when breaking a seal is sneaked into the problems such as danger in the medicinal liquid in addition.And then the danger that contained aluminum is dissolved in the medicinal liquid in glass ampule also appears in the warning of U.S. food pharmaceuticals office (FDA).Therefore, in recent years constantly with there not being the plastic ampoule of above-mentioned danger to replace.
General polyethylene (PE), the polypropylene polyolefin such as (PP) that flexibility is arranged and confirm safety that use of the plastics that form ampoule.PE and PP are to the acid and highly stable material of alkalescent medicine, but very high because of its absorption, permeability to oxygen, air, carbon dioxide etc., are not suitable as the formation material of the ampoule of the medicament that holds easy oxidation, medicinal liquid.Particularly under the situation of the ampoule of low capacity,, can produce the problem that liquor strength enlarges markedly because follow seeing through inner capacities and can reducing of moisture.
Therefore, the moulding material for blow molded products such as film shaped goods such as transfusion bag and infusion bottles is carrying out various researchs and is adopting the polylayer forest (laminated body) of giving the ability (barrier) that prevents in gas and the steam permeable container.
The laminated body of plastics extensively adopts when the manufacturing of thin film and thin plate, but because it is inappropriate using thin film or thin plate in the manufacturing of ampoule, must adopt blow molding in the manufacturing of ampoule.
The ampoule that forms according to blow molding is recorded in No. 2914826 communique of patent and the clear 60-24844 communique of Te Kai.The ampoule (health product container) of the former record is to use the goods of poly-cycloolefin blow molding, and the ampoule of latter's record (container that the inclosure injection medicament is used) is to have the anti-gas-bearing formation that made by the saponification resultant of ethylene-vinyl acetate copolymer (EVA) etc. the goods as the intermediate layer.
But, only put down in writing the theme that only forms ampoule in these documents by blow molding.And the sealing of ampoule is by after injecting medicinal liquid or dropping into medicament in these documents, seals this opening with the heat-sealing that does not produce joint, finishes sealing like this.In this case, have and when forming heat seal lands, follow the ruined worry of heating multiple structure, the incident worry that prevents that effect, effect such as gas permeation from suffering damage when its result has the multiple structure that adopts poly-cycloolefin and EVA.
On the other hand, other manufacture methods as the plastic ampoule of filling medicinal liquid can enumerate so-called blowing, fill, seal method (opens clear 33-8078 communique with reference to the spy, special public clear 36-5985 communique, the homepage of rommelag company " Welcome torommelag (R); " " BFS Process-The bottelpack (R) Process ", " retrieval on March 19th, 2003 ", the Internet<URL; Http:// www.rommelag.com/ 〉).
Blowing, fill, the method for sealing is to form ampoule itself by the molten plastic parison of living tubular with main die clamp, after then filling medicinal liquid, carry out the formation and the sealing of ampoule head continuously with head mould, because the filling of the shaping of ampoule, medicinal liquid, the sealing of ampoule are carried out continuously, be the method that differs widely not only with only comparing with blow-moulding process, and can realize further that aseptic medicinal liquid injects, having can mass-produced advantage.
But, by blowing, the ampoule of filling, sealing manufactured is well known that the individual layers by polyolefin prepared such as PE and PP.Thereby, existing situation be for by blowing, fill, seal the ampoule of manufactured multiple structure, and 1 floor that forms this laminated construction for gas, water vapour, light and medicine prevent the ability (barrier) that sees through and to the ability that prevents of the absorption absorption of medicine all without any correlational study (with reference to the homepage of special public clear 33-8078 communique, special public clear 36-5985 communique, aforesaid rommelag company, the homepage of mutual company (" packaging facilities-container be shaped aseptic fill system ", " retrieval on March 19th, 2003 ", the Internet<URL; Http:// www.mutual.co.jp 〉), homepage (" polyethylene bottle ", " retrieval on March 19th, 2003 ", the Internet<URL of Ri Xin drugmaker; Http:// www.yg-nissin.co.jp/BFS.htm 〉)).
For give to gas, water vapour, light and medicine prevent see through (barrier), to the ability that prevents of drug absorption absorption, for example consider to have and in having the bag of gasproof body permeability, hold the preservation ampoule, or prevent that with having the material that light sees through ability (light barrier) from covering the ampoule surface, or the method for carrying out outer package.But these methods must separately be used the material of bag container and covering surfaces, thereby manufacturing step becomes complicated, have problems such as manufacturing cost rising.
Summary of the invention
The object of the present invention is to provide gas, light or the medicine that can prevent beyond water vapour, the water vapour to leach to the inner immersion of ampoule or to the ampoule outside, the medicament that perhaps holds in ampoule, medicinal liquid, solvent etc. are to the medicinal liquid filled plastics ampoule and the manufacture method thereof of the absorption absorption of ampoule inner surface.
In order to solve above-mentioned problem, the feature of filling medicinal liquid plastic ampoule of the present invention is as follows, it has the container body part of flexibility, the fused portion that seals the opening of this container body part twists off the grip portion that fused portion is used with being connected on this fused portion, the said vesse main part, fused portion and grip portion are with having 2 layers or above integrally formed the making of tubular parison, the said vesse main part is to be shaped with dividing die clamp to live in to state parison, medicinal liquid is filled by portion within it, the closed peristome position makes then, and at least 1 layer of above-mentioned parison prevents gas permeation for having to be selected from, prevent steam permeable, prevent that light from seeing through, prevent that medicine from seeing through and preventing the functional layer of at least one characteristic of the ability that drug absorption is adsorbed.
According to the plastic ampoule of above-mentioned filling medicinal liquid,, can under aseptic condition, realize injection, the sealing of medicinal liquid because in the manufacturing of ampoule, adopt blowing, fill, seal method.In addition, the filling medicinal liquid of the invention described above with plastic ampoule with by behind the filling medicament in the ampoule of the hollow that forms to blow molding, fuse product (with reference to No. 2914826 communique of patent or special record of opening in the clear 60-24844 communique) difference that opening prepares in the mode that does not produce joint, in the fusion of opening, do not have layer and constitute the worry that is damaged.Therefore, filling medicinal liquid plastic ampoule of the present invention can also be given full play to the desired characteristic (barrier properties for gases etc.) in ampoule shaping back.
The desired characteristic of functional layer of the present invention can be enumerated and prevent gas permeation (barrier properties for gases), prevents steam permeable (water vapor barrier), prevent that light from seeing through (light barrier), preventing that medicine from seeing through (medicine barrier) and preventing the ability that drug absorption is adsorbed.These characteristics kind according to the plastic material in the part of using as functional layer in the parison and its compounding agent as described below decides.
In addition, open the spy and to have put down in writing the plastic ampoule that can twist off the filling medicinal liquid that handle part assigns to break a seal in the 2001-70399 communique, so put down in writing this ampoule can be with blowing, fill, seal the theme of manufactured and multiple stratification or give the theme (section [0007], [0012]) of its light-proofness as required.But, to about multiple stratification parison itself, or give the barrier of the whole expectation of ampoule without any concrete record and suggestion in this communique by in parison, mixing the layer that material with above-mentioned functions makes.
The innermost layer of filling medicinal liquid plastic ampoule of the present invention used parison in it is shaped preferably forms by the resin that contains polyolefin or poly-cycloolefin.
By with containing the innermost layer of the resin of polyolefin or poly-cycloolefin as parison, fill medicinal liquid with the innermost layer of plastic ampoule can be to use also that the resin that contains polyolefin or poly-cycloolefin makes layer.Polyolefin and poly-cycloolefin are the materials stable, that safety obtains confirming, thereby at its innermost layer the filling medicinal liquid that polyolefin or poly-cycloolefin make are set and are suitable as container for medical use with plastic ampoule.
Filling medicinal liquid plastic ampoule of the present invention, the parison that uses during it is shaped is to have at least 1 layer to be the layer that at least one medicament that mixed to be selected from coloring agent, UV absorbent and oxygen absorbent makes except innermost layer, and than the layer of this layer inside preferably have prevent medicine see through ability layer.
To make the layer that mixed colorant and/or UV absorbent form except at least 1 layer of parison innermost layer, can give the filling medicinal liquid thus and see through ability (the light barrier is the barrier to light, ultraviolet etc. specifically) to prevent light with plastic ampoule.And, mix the layer that oxygen absorbent forms by making except at least 1 layer of parison innermost layer, can give the filling medicinal liquid thus and use plastic ampoule in case block gas sees through ability (oxygen-barrier property).
Mixed layer that coloring agent, UV absorbent or oxygen absorbent make in the worry that has the contained strippings such as coloring agent in its inside when medicinal liquid etc. directly contacts.But, according to above-mentioned filling medicinal liquid plastic ampoule because the layer that has mixed coloring agent etc. inboard be provided with to have prevent that medicine from seeing through the layer of ability, can prevent to produce coloring agent etc. and be dissolved in such problem in the medicinal liquid that ampoule holds.
As the layer that has mixed above-mentioned coloring agent etc. inboard that be provided with, have and prevent that the layer that medicine sees through ability from can enumerate polyhydric alcohol layer described later, polyester layer and poly-cycloolefin layer.
Filling medicinal liquid plastic ampoule of the present invention, the functional layer of its used parison in being shaped is preferably
(i) contain the goods of aramid layer,
The goods that (ii) contain the polyhydric alcohol layer,
The goods that (iii) contain polyester layer, perhaps
The goods that (iv) contain poly-cycloolefin layer.
When preparing the functional layer of the aramid layer that contains above-mentioned (i), can give the ability that medicinal liquid prevents gas permeation with plastic ampoule and prevents steam permeable of filling.Thereby this ampoule can be suitable for holding for example easily oxidation, the medicinal liquid that can not preserve in the presence of oxygen and because the medicinal liquid of significant change takes place the variation drug effect of moisture etc.
When preparation contains the functional layer of above-mentioned polyhydric alcohol layer (ii), can give the filling medicinal liquid and prevent gas permeation, prevent steam permeable, prevent that medicine from seeing through and preventing the ability of drug absorption absorption with plastic ampoule.Thereby this ampoule can be suitable for holding the medicinal liquid that for example can not preserve and the medicinal liquid of significant change can be taken place by variation drug effect of moisture etc. in the presence of oxygen.
For example, when ampoule has the layer of medicaments such as containing coloring agent, UV absorbent, oxygen absorbent,, can prevent that mentioned reagent is dissolved in the medicinal liquid of filling in the ampoule by the polyhydric alcohol layer is set in this layer inboard.
When preparation contains the functional layer of above-mentioned polyester layer (iii), can give the filling medicinal liquid and prevent gas permeation, prevent steam permeable, prevent that medicine from seeing through and preventing the ability of drug absorption absorption with plastic ampoule.Thereby this ampoule can be suitable for holding the medicinal liquid that for example can not preserve and the medicinal liquid of significant change can be taken place by variation drug effect of moisture etc. in the presence of oxygen.And, by using the innermost layer of polyester layer, can prevent absorption or the absorption of medicine to the ampoule innermost layer as ampoule.
Poly-cycloolefin because have prevents that medicament from absorbing, the ability of absorption, prevent the ability (medicine barrier) that medicine sees through, the ability that prevents steam permeable, and the transparency is good, and the formation material (spy opens flat 5-277154 communique) of attempting using it for container for medical use has been arranged.Thereby preparation is when containing the functional layer of above-mentioned poly-cycloolefin layer (iv), can give filling medicinal liquid and preventing that with plastic ampoule medicine from seeing through (medicine barrier), prevent drug absorption absorption, preventing the ability of steam permeable.
And, for example, when ampoule has the layer of medicaments such as containing coloring agent, UV absorbent, oxygen absorbent,, can prevent that the mentioned reagent stripping is in the medicinal liquid that is filled in the ampoule by poly-cycloolefin layer is set in this layer inboard.
When using poly-cycloolefin layer, can prevent absorption or the absorption of medicine to the ampoule innermost layer as the ampoule innermost layer.And then in this case, preferably using glass transition temperature (Tg) as the poly-cycloolefin that forms innermost layer is 110 ℃ or following product.By using the poly-cycloolefin of glass transition temperature at innermost layer in above-mentioned scope, for blowing, fill, seal joint (joint of main mould and the head mould) part of the finishing die of method, can prevent to fill, the sealing back produces the liquid leakage at content liquid.The glass transition temperature of poly-cycloolefin in above-mentioned scope preferred especially 60~105 ℃, more preferably 60~80 ℃.
In addition, open the example of having put down in writing the ampoule that uses poly-cycloolefin shaping in the flat 5-293159 communique the spy, but in the document for blowing, fill, seal the manufactured ampoule without any record, leak the generation of problem and solution liquid thereof not instruction and hint for above-mentioned liquid.
By the way, the glass transition temperature of poly-cycloolefin surpasses 110 ℃, generally has shortage to the patience of bending stress, more crisp feature itself.Thereby, use has with glass transition temperature at the innermost layer of 110 ℃ or following poly-cycloolefin preparation with contain the polylayer forest of layer that glass transition temperature surpasses 110 ℃ poly-cycloolefin and form and fill the medicinal liquid plastic ampoule, can prevent that filling, sealing back at content liquid from producing the liquid leakage, and pass through the fused portion (thin place) of crooked or distortion ampoule etc., can easily carry out the Kaifeng operation of ampoule.
In addition, compare with the general and poly-cycloolefin of polymer that acyclic alkene makes, the flexibility of its formed body is higher, excellent impact resistance.Thereby, when the lamilated body that forms plastic ampoule not only has the layer that contains cyclic olefin, when also having the polyolefinic layer of the non-annularity of containing, can improve the impact resistance of plastic ampoule integral body.
Filling medicinal liquid plastic ampoule of the present invention also can be with the connector of a plurality of ampoules of broken thin part connection, prepares the management that such connector for example can easily hold a plurality of ampoules of medicinal liquid of the same race.
Filling medicinal liquid plastic ampoule of the present invention is when layer that has the steam permeable of preventing or prevent the drug absorption absorbability in functional layer, can be the ampoule of 0.5~20mL as inner capacities.That is, the aramid layer of above-mentioned for having (i), above-mentioned (ii) the polyhydric alcohol layer, above-mentioned (iii) polyester layer or above-mentioned (iv) poly-cycloolefin layer as the plastic ampoule of functional layer, being suitable for inner capacities is the low capacity ampoule of 0.5~20mL.Inner capacities is that the ampoule of 0.5~20mL is few because of the absolute magnitude that it holds solution, following the volatilization of solvent or medicament to be absorbed during ampoule holds is adsorbed onto on the ampoule, can produce the so-called problem of holding the character significant change of solution, prevent steam permeable, prevent good aramid layer, polyhydric alcohol layer, polyester layer or poly-cycloolefin layers etc. such as drug absorption absorbability by setting, can prevent the generation of this problem.
Filling medicinal liquid of the present invention is characterized in that comprising the following steps: can dividing die clamp firmly to have the tubular parison of 2 or above layer with the partially-formed usefulness of container body following with the manufacture method of plastic ampoule, wherein at least 1 layer is to have to be selected to prevent gas permeation, prevent steam permeable, prevent that light from seeing through, preventing that medicine from seeing through and preventing the functional layer of at least one characteristic of drug absorption, absorption, after the inside of tubular parison forms the cavity and comes the forming containers main part
In this container body part, fill medicinal liquid, then,
Use the opening that can divide die clamp to live this container body part, the fused portion that forms this opening of sealing is used to twist off the grip portion of fused portion with linking to each other with this fused portion.
According to above-mentioned manufacture method, can under aseptic condition, realize to filling medicinal liquid with injecting, seal medicinal liquid in the plastic ampoule.And, after filling medicinal liquid, during the opening of fusion sealing ampoule, can not destroy the layer structure of laminated plastics, form fused portion.
Thereby, above-mentioned manufacture method of the present invention be very suitable for making can prevent gas, water vapour, light and medicament to inner or outside see through or ampoule in medicament, medicinal liquid, solvent etc. absorb or the filling medicinal liquid plastic ampoule of absorption to inner surface.
Filling medicinal liquid of the present invention preferably uses (a) its innermost layer to be formed by the resin that contains polyolefin or poly-cycloolefin with the parison in the manufacture method of plastic ampoule, perhaps (b) except at least 1 layer of its innermost layer layer at least one medicament that mixed to be selected from coloring agent, UV absorbent and oxygen absorbent, and the layer of this layer inboard prevents that for having medicine from seeing through the layer of ability.
Under the situation of above-mentioned (a), can more safely make container for medical use with plastic ampoule by the filling medicinal liquid that said method obtains.
In above-mentioned (a), innermost layer is by under the situation that contains the resin formation that gathers cycloolefin, according to reason same as described above, preferably use glass transition temperature at 110 ℃ or following product as this poly-cycloolefin, more preferably using glass transition temperature is 60~105 ℃ product.
And, under the situation of above-mentioned (a), according to reason same as described above, as parison preferably use have the innermost layer that forms at 110 ℃ or following poly-cycloolefin by glass transition temperature and by glass transition temperature surpass that 110 ℃ poly-cycloolefin forms layer product.
Under the situation of above-mentioned (b), can give the filling medicinal liquid that obtains by said method and see through ability (to the barrier of light, ultraviolet etc.) to prevent light with plastic ampoule.
Brief description of drawings
Fig. 1 is the partial cross section figure of expression filling medicinal liquid of the present invention with an embodiment of plastic ampoule, (a) is front elevation, (b) is right hand view.
Fig. 2 is the partial cross section front elevation of expression filling medicinal liquid of the present invention with other embodiments of plastic ampoule.
The specific embodiment
The filling medicinal liquid that then present invention will be described in detail with reference to the accompanying plastic ampoule and preparation method thereof.
<filling medicinal liquid plastic ampoule 〉
Fig. 1 and Fig. 2 are the accompanying drawing of expression filling medicinal liquid of the present invention with an embodiment of plastic ampoule.
Filling medicinal liquid shown in Fig. 1 with plastic ampoule 10 have the container body part 11 of flexibility and closed container main part opening 12 fused portion 13, be connected in the grip portion 14 on the fused portion 13.
Filling medicinal liquid shown in Fig. 2 is the same with ampoule 10 shown in Figure 1 with plastic ampoule 18, have the container body part 11 of flexibility and closed container main part opening 12 fused portion 13, be connected in the grip portion 14 on the fused portion 13.For this ampoule 18, between lateral edge portions 17, connect by the coupling part 19 that can twist off.
Filling medicinal liquid can separate from fused portion 13 by crooked or distortion with the grip portion 14 of plastic ampoule.Twist off grip portion 14, it is separated with container body part 11 from fused portion 13, the opening portion 12 of container body part 11 is opened, can obtain, sealing in the amount discharge container main part 11, the medicinal liquids 15 of filling.
In addition, when the polylayer forest that forms ampoule 10,18 has the layer that contains the poly-cycloolefin of glass transition temperature above 110 ℃,, can carry out lock out operation simply from fused portion 13 according to aforementioned reason.
Form filling medicinal liquid, to it is characterized by its at least 1 layer with the plastics 16 of plastic ampoule be to have to be selected to prevent gas permeation, prevent steam permeable, prevent that light from seeing through, preventing that medicine from seeing through and preventing the functional layer of at least one characteristic of drug absorption absorbability.
Fill medicinal liquid with the lateral edge portions 17 of plastic ampoule for by the blowing of this ampoule, when filling, sealing the method shaping, sandwich parison with die head and form.Filling medicinal liquid for example can use the bull coventry type die head coventry that has with corresponding die head of the number of the ampoule that is connected and mould to be shaped with plastic ampoule 18.
<ampoule moulding material 〉
For filling medicinal liquid plastic ampoule of the present invention, the functional layer that contains in this ampoule has following feature as mentioned above, and it has to be selected from and prevents gas permeation, prevents steam permeable, prevents that light from seeing through, preventing that medicine from seeing through and preventing at least one characteristic of drug absorption absorbability.Corresponding about the kind of this characteristic and the plastic material that in this functional layer, uses, as mentioned above.
As operable polyamide among the present invention without limits, for example nylon-6, nylon-6 can have been enumerated, 6, nylon-6,12, PA-12, xyxylene diamidogen polyamide etc. at this.
As operable polyester among the present invention without limits, still for example polyethylene terephthalate (PET), PEN, polybutylene terephthalate (PBT) etc. can have been enumerated at this.
As operable polyhydric alcohol among the present invention without limits, still for example polyvinyl alcohol (PVOH), ethylene-vinyl alcohol copolymer (EVOH) etc. can have been enumerated at this.
As operable poly-cycloolefin among the present invention without limits, can enumerate the ring opening copolymer thing of the copolymer of copolymer, ethylene and the norborene compounds of ethylene and bicyclopentadiene class, the ring-opening polymerization polymer of cyclopentadiene derivant, a plurality of cyclopentadiene derivants and hydrogenated products thereof etc. at this.
Among the present invention, especially preferably use the hydrogenation products of open loop (being total to) polymer of the hydrogenation products of copolymer of ethylene and norborene compounds or a kind or above cyclopentadiene derivant in the above-mentioned poly-cycloolefin that exemplifies.Should gather cycloolefin by using, and can prepare ampoule intensity and prevent that moisture from seeing through the better layer of ability, and can also give the ability that ampoule prevents gas permeation.
For above-mentioned poly-cycloolefin, can enumerate the polymer that for example has the repetitive of representing with the repetitive and the general formula (1 ') of general formula (1) expression, have polymer with the repetitive of general formula (2) expression.
(in formula (1) and the formula (1 '), R
1, R
1', R
2And R
2' can be identical or different, expression hydrogen, hydrocarbon residue or halogen, ester group, nitro, pyridine radicals isopolarity group.R
1, R
1', R
2And R
2' ring formation also can mutually combine.M and m ' are the integer more than 1 or 1, and n and n ' are the integer more than 0 or 1 or 1.)
(in the formula (2), R
3And R
4Can be identical or different, expression hydrogen, hydrocarbon residue or halogen, ester group, nitro, pyridine radicals isopolarity group.R
3And R
4Ring formation also can mutually combine.X and z are the integer more than 1 or 1, and y is the integer more than 0 or 1 or 1.)
The polymer of repetitive with general formula (1) and (1 ') expression is by a kind of known ring-opening polymerization method polymerization or 2 kinds or the monomer more than it, perhaps the product that makes of the ring-opening polymerization polymer hydrogenation that then will obtain like this with conventional method.Can enumerate the commodity of the commodity " ゼ オ ノ ア (registered trade mark) " by name that Japanese ゼ オ Application company makes, the commodity " ARTON (registered trade mark) " by name that Japan SYnthetic Rubber Co. Ltd makes etc. as the object lesson of this polymer.
Polymer with construction unit of general formula (2) expression is as monomeric a kind or 2 kinds or norborneol alkene monomer and ethylene more than it, and/or with its product with the conventional method hydrogenation preparing by the known method addition copolymerization.Can enumerate the commodity of the commodity " ア ペ Le (registered trade mark) " by name of Mitsui Chemicals company manufacturing, the commodity " ト パ ス (registered trade mark) " by name that テ イ コ Na GmbH company makes etc. as the object lesson of this polymer.
Have in the polymer of repetitive of above-mentioned general formula (1), (1 ') and (2) expression, because any of its hydrogenation products all is saturated polymer, it is except having gas shield and covering property of moisture, from the thermostability and the transparency, further also good from stability.
The melt flow index of the poly-cycloolefin that uses among the present invention (MFR) is from the formability of ampoule and the preferred 4~30g/10 of viewpoints such as mechanical characteristic minute (190 ℃) of molded article.
The molecular weight of the poly-cycloolefin that uses among the present invention is not particularly limited, but number-average molecular weight (Mn) is preferred 10,000~100,000, and more preferably 20,000~50,000.Need to prove that molecular weight for example can be measured by gel permeation chromatography (GPC) analysis of cyclohexane give solvent.
Among the present invention, except above-mentioned example, can also enumerate improved polyalkene for example, Vingon (have the gas permeation of preventing, prevent the ability of steam permeable), polyacrylonitrile (have the gas permeation of preventing, prevent steam permeable, prevent that medicine from seeing through, preventing the ability of drug absorption absorption) etc. as the resin that can in the shaping of functional layer, use.
Can enumerate product (for example improved polyalkene of unsaturated carboxylic acid such as glycerol polymerization maleic acid etc.) of functional group such as addition carboxyl in polyolefin such as non-polar polymer polyethylene or polypropylene etc. as the polyolefin of modification.Concrete example has the cementability polyolefin that Mitsui Chemicals company for example makes [trade name " ア De マ-(R) LB540 ", " ア De マ-(R) NF510 ", " ア De マ-(R) UF300 " etc.]; The high adhesiveness resin [trade name " モ デ ィ ッ Network-AP (R) P512V ", " モ デ ィ ッ Network-AP (R) L103 " etc.] that Mitsubishi Chemical Ind makes etc.These improved polyalkenes can be selected aptly according to the resin kind of adhesion layer.
Have prevent light see through ability (light barrier) the layer formation in, can in plastics, mix following pigment, UV absorbent.As the pigment that in the formation of light barrier material, uses without limits, for example can enumerate inorganic pigment such as titanium oxide, zinc oxide, carbon black, iron oxide red, silicon dioxide and phthalocyanine system, azo system at this, quinoline a word used for translation ketone is organic pigment etc.
On the other hand, as the UV absorbent of using in the formation of light barrier material at this without limits, for example having enumerated, salicylic acid such as phenyl salicytate, salicylic acid p-octyl octylphenyl is a UV absorbent; 2, benzophenone series UV absorbent such as 4-dihydroxy benaophenonel, two (2-methoxyl group-4-hydroxyl-5-benzo base phenyl) methane; 2-ethylhexyl-2-cyano group-3,3-diphenylacrylate ester and ethyl-2-cyano group-3, cyanoacrylates such as 3-diphenylacrylate ester are UV absorbent; 2-(5-methyl-2-hydroxy phenyl) benzotriazole, 2-(the 3-tert-butyl group-5-methyl-2-hydroxy phenyl)-benzotriazole systems such as 5-chlorinated benzotriazole etc.Above-mentioned pigment or UV absorbent are added about preferably with 0.01~5 weight % in the plastics that constitute light barrier layer.
Have prevent gas permeation ability (barrier properties for gases) the layer in, particularly have oxygen-barrier property the layer formation in, can in plastics, mix oxygen absorbents such as ferrum, sodium sulfite, sodium sulfite, pyrogallol, ascorbic acid, tocopherol.Oxygen absorbent adds about preferably with 0.15~5 weight % in the plastics that form the oxygen-barrier property layer.
For filling the plastic ampoule that medicinal liquid is used among the present invention, the general use of the layer polyolefin except this functional layer forms and is fit to.Can enumerate used various polyolefin in the existing medical plastic containers such as polyethylene, polypropylene as this polyolefin.And, can also mix adhesive resins such as unsaturated carboxylic acid-modified polyethylene, ethylene-acrylic acid copolymer, ethylene-vinyl acetate copolymer at interlayer as required.For the plastics that form these other layers, cooperate the shape of layer structure and container etc., character such as density, MFR can suit to select in relative broad range.
Operable polyolefin is not particularly limited among the present invention, can adopt known various polyolefin at present.In addition, in various polyolefin, especially preferably use polyethylene or polypropylene.
In polyethylene (PE), can use so-called high-pressure process (chain) low density polyethylene (LDPE) (HP-LDPE), straight chain shape low density polyethylene (LDPE) (LLDPE), medium density polyethylene (MDPE), high density polyethylene (HDPE) various PE such as (HDPE).The density of PE can be at 0.900g/cm
3~0.965g/cm
3The general range of PE plastics in suitable the selection.From considering, preferably in more low-density scope, be specially 0.910~0.930g/cm with the formability of the layer that makes with poly-cycloolefin or the viewpoints such as mechanical characteristic of ampoule
3Scope in select.The melt flow index of PE (MFR) considers to be preferably 0.2~20g/10 minute (190 ℃) from the formability of the layer that makes with poly-cycloolefin and the viewpoints such as mechanical characteristic of ampoule.
PE is not limited to homopolymer, also can be copolymer.This moment is as alpha-olefines such as the preferred 1-butylene of comonomer, 1-amylene, 1-hexene, 4-methyl-1-pentene, 1-octene, 1-decene.The content ratio of comonomer is preferably at 20 moles of % or following, more preferably about 3~20 moles of %.
Kind, the character of polypropylene (PP) also are not particularly limited, and adopt general isotaxy PP or a rule PP (being the crystallinity homopolymer) or are fit to its crystallinity copolymer of making main composition as PP.Comonomer in this crystallinity copolymer is preferably alpha-olefines such as ethylene, 1-butylene.Containing of comonomer is proportional preferably at 30 moles of % or following, more preferably about 2~30 moles of %, more preferably about 3~25 moles of %.The melt flow index of PP (MFR) is from considering to be preferably 0.2~20g/10 minute (190 ℃) with the formability of the layer that makes with poly-cycloolefin and the viewpoints such as mechanical characteristic of ampoule.
In order to give the ability (oxygen-barrier property) that plastic ampoule of the present invention prevents that oxygen from seeing through, can in plastics, mix oxygen absorbents such as ferrum, sodium sulfite, sodium sulfite, pyrogallol, ascorbic acid, tocopherol.Oxygen absorbent preferably adds with the amount about 0.15~5 weight % in the plastics that form the oxygen-barrier property layer.And, form in the plastics of plastic ampoule of the present invention and can suit to mix in right amount stabilizing agents such as butylated hydroxytoluene, eight decyls-3-(3, the 5-di-tert-butyl-hydroxy phenyl) propionic ester; Antibacterial such as silver-zeolite, hinokitiol; Plasticizers such as phthalic acid ester etc.Under the situation of the plastics that use to mix these additives, preferably ampoule is made polylayer forest, and the plastic layer that will mix above-mentioned additive is made the layer beyond the internal face.
The layer structure of<ampoule 〉
The innermost layer of the plastic ampoule of filling medicinal liquid of the present invention preferably uses with polyethylene or polypropylene polyolefin or the poly-cycloolefin as representative.Polyolefin or poly-cycloolefin will have the safety and the stability of pair medicament, medicinal liquid as mentioned above, and then require fused property also good.
Have and prevent that the layer that medicine sees through ability (medicine barrier) is arranged on the innermost layer outside of plastic ampoule, and, can give full play to the action effect of medicine barrier layer, so preferred in the inboard of other functional layer.
<intermixture etc. 〉
Forming filling medicinal liquid of the present invention also can mix as required with the plastics of plastic ampoule.And, can suit to mix in right amount stabilizing agents such as butylated hydroxytoluene, eight decyls-3-(3, the 5-di-tert-butyl-hydroxy phenyl) propionic ester as required; Antibacterial such as silver-zeolite, hinokitiol; Plasticizers such as phthalic acid ester etc.
Preferably be arranged on the outside of medicine barrier layer for mixing layer that such additive makes.
<manufacture method etc. 〉
Filling medicinal liquid of the present invention can use the blowing, filling, the sealing machine that have multilamellar extruder and multilamellar blowing mould to make with plastic ampoule.
Specifically, at first use the multilamellar blowing mould to be formed with 2 tubular parisons with the upper strata by extrusion molding.At least 1 layer of use has to be selected from and prevents gas permeation (barrier properties for gases), prevents steam permeable (moisture barrier), prevents that light from seeing through (optics barrier), preventing that medicine from seeing through (medicament barrier) and preventing the functional layer of at least one characteristic of the ability of drug absorption absorption in this parison.Then, live this tubular parison, air is pressed into its inside, perhaps attract parison to form the container body part, at the medicinal liquid of partially filled regulation of this container body and ormal weight with the die face hole with the following die clamp that can divide of the partially-formed usefulness of container body.And then, use the peristome that can divide die clamp to live this container body part, by fused portion that forms this opening of sealing and the grip portion that fused portion is used that twists off that is connected on this fused portion, can make filling medicinal liquid plastic ampoule of the present invention.The layer structure of parison can suit to set according to the desired layer of the plastic ampoule of filling medicinal liquid structure.
According to blowing, the ampoule of filling, sealing method creates conditions and is not particularly limited, can be according to common creating conditions.Melt extruding temperature or melt extruding speed of parison can be according to the suitable settings such as shape of used resin and purpose container.
About preferred 300~2000 μ m of gross thickness of the plastic ampoule of filling medicinal liquid.The thickness of functional layer is not particularly limited, and can wait suitable the selection according to the kind and the application target of the function that this layer had, and is preferably usually about 10~300 μ m.
<medicament, the medicinal liquid that can hold 〉
The medicinal liquid that holds in the plastic ampoule of the present invention is not particularly limited, and can suit according to the functional characteristic that functional layer has to select.
For example, in the plastic ampoule of the present invention, can hold with the goods that have the layer that prevents gas permeation ability (barrier properties for gases) for the solution of easy oxidation medicament.Can enumerate for example vitamins such as vitamin A as easy oxidation medicament; Aminoacid such as cysteine, tryptophan; Reduced glutathion, lipomul, Liposomal formulation etc.
For the solution of light deterioration medicament, in the ampoule of the present invention, can with have prevent light see through ability (light barrier) the layer goods hold.Can enumerate for example vitamins such as vitamin B2, vitamin B12 as light deterioration medicament; Hydrochloric acid bromhexine, saccharated iron oxide agent, atropine sulfate, neostigmine, dimethyl-aminopropionyl-aminoanti-pyrine, haloperidol, ephedrine hydrochloride etc.
For the solution that absorbs the adsorptivity medicament, can hold with the goods that have the layer that prevents the drug absorption absorbability in the ampoule of the present invention.Vitaminss such as vitamin D for example can have been enumerated as absorbing the adsorptivity medicament; Nitroglycerine; Elcatonin (elcatonin) etc.
[embodiment]
Then enumerate the plastic ampoule that embodiment illustrates medicinal liquid filling usefulness of the present invention.
Fill the formation material of the plastic ampoule of usefulness for medicinal liquid, its abbreviation, rerum natura etc. are shown below.
(polyolefin)
PE1: ethylene butene-1 copolymer (density 0.92g/cm
3, melt flow index (MFR) 1.0g/10min (190 ℃), trade name " ウ Le ト ゼ ッ Network ス 2010B ", Mitsui Chemicals company makes)
PE2: every part of goods that mix the organic pigment (trade name " Network ロ モ Off Le イ エ ロ-GR " and " Network ロ モ Off Le イ エ ロ-AGR " are that チ バ ガ イ ギ-company makes) of 0.2 weight % in PE1.(have and prevent that ultraviolet from seeing through the plastics of function (ultraviolet isolating))
PE3: the goods that in PE1, mix the sodium sulfite as oxygen absorbent (mean diameter is about 8 μ m) of 10 weight %.(have and prevent that oxygen from seeing through the plastics of function (oxygen-barrier property))
PP1: isotactic polypropylene (density 0.91g/cm
3, MFR1.6g/10min (230 ℃), Article Number " J704 ", Mitsui Chemicals company makes)
PP2: every part of goods that mix the organic pigment (trade name " Network ロ モ Off Le イ エ ロ-GR " and " Network ロ モ Off Le イ エ ロ-AGR ") of 0.2 weight % in PP1.(have and prevent that ultraviolet from seeing through the plastics of function)
(improved polyalkene)
AD1: maleic acid modified poly ethylene (density 0.92g/cm
3, MFR0.9g/10min (190 ℃), trade name " ア De マ-NB550 ", Mitsui Chemicals company makes)
(polyhydric alcohol)
EVOH1: ethylene-vinyl alcohol copolymer (175 ℃ of fusing points, MFR1.6g/10min (190 ℃), trade name " エ バ-Le EP-H101 ", Network ラ レ company makes)
(poly-cycloolefin)
COP1: norborene is monomeric ring-opening polymerization polymer hydrogenation products (105 ℃ of glass transition temperatures (Tg), trade name " ゼ オ ノ ア 1020R ", Japanese ゼ オ Application company makes for proportion 1.01, MFR20g/min (280 ℃))
COP2: norborene is monomeric ring-opening polymerization polymer hydrogenation products (Tg is 70 ℃ for proportion 1.01, MFR27g/min (280 ℃), trade name " ゼ オ ノ ア 750R ", Japanese ゼ オ Application company makes)
COP3: norborene is monomeric ring-opening polymerization polymer hydrogenation products (Tg is 136 ℃ for proportion 1.01, MFR20g/min (280 ℃), trade name " ゼ オ ノ ア 1420R ", Japanese ゼ オ Application company makes)
COC1: the copolymer of ethylene and tetracyclododecen (Tg is 105 ℃ for proportion 1.03, MFR25g/10min (260 ℃), trade name " ア ペ Le APL6011T ", Mitsui Chemicals company makes)
COC2: the copolymer of ethylene and tetracyclododecen (Tg is 80 ℃ for proportion 1.02, MFR40g/10min (190 ℃), trade name " ア ペ Le APL6509 ", Mitsui Chemicals company makes)
COC3: the copolymer of ethylene and tetracyclododecen (Tg is 70 ℃ for proportion 1.02, MFR40g/10min (190 ℃), trade name " ア ペ Le APL8008 ", Mitsui Chemicals company makes)
(polyamide)
NY1: m-xylene diamine-adipic acid condensation polymer (SANLING gas chemical company makes for 243 ℃ of fusing points, trade name " MX nylon 6001 ")
(polyester)
PET1: polyethylene terephthalate (trade name " Mitsui PET ", Mitsui Chemicals company makes)
The manufacturing of the plastic ampoule of<filling medicinal liquid 〉
(embodiment 1)
Use has blowing, filling, the sealing machine of 2 layers of blowing mould, prepare outer by COP1 (poly-cycloolefin) preparation internal layer, PE1 (polyolefin), and 0.005% nitroglycerine aqueous solution 10mL fills in portion within it, makes the filling medicinal liquid plastic ampoule (internal volume 10mL) that 2 layers of structure are arranged.This ampoule 10 has shape shown in Figure 1, and thickness of pipe wall is internal layer 100 μ m, outer 700 μ m.
(embodiment 2)
Use has blowing, filling, the sealing machine of 2 layers of blowing mould, by COP1 (poly-cycloolefin) and PE1 (polyolefin) with the plastics of the mixed of 50: 50 (weight ratio) prepare internal layer, PP1 (polyolefin) prepares skin, and 0.005% nitroglycerine aqueous solution 20mL fills in portion within it, makes the filling medicinal liquid plastic ampoule (internal volume 20mL) that 2 layers of structure are arranged.This ampoule 10 has shape shown in Figure 1, and thickness of pipe wall is internal layer 100 μ m, outer 700 μ m.
(embodiment 3)
Use has blowing, filling, the sealing machine of 3 layers of blowing mould, prepare outer by PE1 (polyolefin) preparation internal layer, COP1 (poly-cycloolefin) preparation intermediate layer, PE1, and 0.005% nitroglycerine aqueous solution 10mL fills in portion within it, makes the filling medicinal liquid plastic ampoule (internal volume 10mL) of the structure that haves three layers.This ampoule 10 has shape shown in Figure 1, and thickness of pipe wall is internal layer 50 μ m, intermediate layer 100 μ m, outer 700 μ m.
(embodiment 4)
As the plastics that form the intermediate layer, use COP1 and PE1 (polyolefin) to replace only using COP1 (poly-cycloolefin) with the plastics of the mixed of 50: 50 (weight ratio), the internal volume of ampoule is 5mL, and the amount of the 0.005% nitroglycerine aqueous solution of filling in ampoule is 5mL, carry out 3 identical operations in addition, make filling medicinal liquid plastic ampoule with 3-tier architecture with embodiment.
(embodiment 5)
Use has blowing, filling, the sealing machine of 5 layers of blowing mould, prepare intermediate layer (internal layer side), COP1 by PE1 (polyolefin) preparation internal layer, COP1 (poly-cycloolefin) and PE1 with the plastics of the mixed of 50: 50 (weight ratio) and prepare that intermediate layer (pars intermedia), COP1 and PE1 prepare intermediate layer (outer layer side) with the plastics of the mixed of 50: 50 (weight ratio) and PE1 prepares skin, and 0.005% nitroglycerine aqueous solution 20mL fills in portion within it, makes the filling medicinal liquid plastic ampoule (internal volume 20mL) of the structure that is of five storeys.This ampoule 10 has shape shown in Figure 1, and thickness of pipe wall is internal layer 50 μ m, and intermediate layer (internal layer side, intermediate layer and outer layer side) respectively is 100 μ m, outer 500 μ m.
(embodiment 6)
As the plastics that form intermediate layer (pars intermedia), use COP1 and PE1 (polyolefin) to replace only with COP1 (poly-cycloolefin) with the plastics of the mixed of 80: 20 (weight ratio), the internal volume of ampoule is 10mL, and the amount at inner 0.005% the nitroglycerine aqueous solution of filling of ampoule is 10mL, carry out 5 identical operations in addition, make medicinal liquid filling plastic ampoule with 5 layers of structure with embodiment.
The performance evaluation of<plastic ampoule 〉
Filling medicinal liquid to embodiment 1~6 was implemented autoclaving 40 minutes down at 106 ℃ respectively with plastic ampoule, preserved for 2 weeks down at 60 ℃ then, was determined at the content of the nitroglycerine of the nitroglycerine aqueous solution of filling in the ampoule.In addition, the medicament that nitroglycerine is absorption, adsorptivity is high.
The measurement result of any one ampoule all is that the remaining quantity of preserving the nitroglycerine after 2 weeks is more than the 95 weight %, and nitroglycerine is to the absorption of ampoule internal face, absorption and soaking into, discharging and also obviously obtained sufficient inhibition to the ampoule outside.That is, the ampoule of embodiment 1~6 is any one prevents drug absorption absorption and prevents that the ability that medicine sees through is all good.This thinks because the ampoule of embodiment 1~6 all has poly-cycloolefin layer.
<table 1 〉
Above: in the middle of the material: below the mixed proportion of resin (weight ratio): layer thickness
The manufacturing of the plastic ampoule of<filling medicinal liquid 〉
(embodiment 7)
Use has blowing, filling, the sealing machine of 3 layers of blowing mould, prepare outer by PE1 (polyolefin) preparation internal layer, EVOH1 (polyhydric alcohol) preparation intermediate layer, PE1, and 0.1% tryptophan aqueous solution 10mL fills in portion within it, makes the filling medicinal liquid plastic ampoule (internal volume 10mL) of the structure that haves three layers.This ampoule 10 has shape shown in Figure 1, and thickness of pipe wall is internal layer 50 μ m, intermediate layer 100 μ m, outer 700 μ m.
(embodiment 8)
Use has blowing, filling, the sealing machine of 5 layers of blowing mould, prepare intermediate layer (outer layer side) and PE1 preparation skin by PE1 (polyolefin) preparation internal layer, AD1 (improved polyalkene) preparation intermediate layer (internal layer side), EVOH1 (polyhydric alcohol) preparation intermediate layer (pars intermedia), AD1, and 0.1% tryptophan aqueous solution 5mL fills in portion within it, makes the filling medicinal liquid plastic ampoule (internal volume 5mL) of the structure that is of five storeys.This ampoule 10 has shape shown in Figure 1, and thickness of pipe wall is internal layer 50 μ m, and intermediate layer (internal layer side and outer layer side) respectively is 10 μ m, and intermediate layer (pars intermedia) is 100 μ m, outer 700 μ m.
(embodiment 9)
Use has blowing, filling, the sealing machine of 4 layers of blowing mould, outer by PE1 (polyolefin) preparation internal layer, PE3 (plastics that oxygen-barrier property is arranged) preparation intermediate layer (internal layer side), EVOH1 (polyhydric alcohol) preparation intermediate layer (outer layer side) and PE1 preparation, and 0.1% tryptophan aqueous solution 10mL fills in portion within it, makes the filling medicinal liquid plastic ampoule (internal volume 10mL) that 4 layers of structure are arranged.This ampoule 10 has shape shown in Figure 1, and thickness of pipe wall is internal layer 50 μ m, and intermediate layer (internal layer side and outer layer side) respectively is 100 μ m, outer 600 μ m.
The performance evaluation of<plastic ampoule 〉
Filling medicinal liquid to embodiment 7~9 was implemented autoclaving 40 minutes down at 106 ℃ respectively with plastic ampoule, preserved for 2 weeks down at 60 ℃ then, was determined at the content of the tryptophan of the tryptophan aqueous solution of filling in the ampoule.In addition, tryptophan is the medicament of easy oxidation.
The measurement result of any one ampoule all is that the remaining quantity of tryptophan after preserving for 2 weeks is more than the 95 weight %, shows that the oxidative degradation of tryptophan has obtained sufficient inhibition.That is, showing that the ampoule of embodiment 7~9 is any one prevents gas permeation (barrier properties for gases, special than be oxygen-barrier property) and prevents that the ability that medicine sees through is all good.This thinks because the ampoule of embodiment 7~9 all has the polyhydric alcohol layer.
The manufacturing of the plastic ampoule of<filling medicinal liquid 〉
(embodiment 10)
Use has blowing, filling, the sealing machine of 3 layers of blowing mould, prepare outer by PE1 (polyolefin) preparation internal layer, COP1 (poly-cycloolefin) preparation intermediate layer, PE2 (ultraviolet isolating plastics), and 0.05% vitamin B2 aqueous solution 10mL fills in portion within it, makes the filling medicinal liquid plastic ampoule (internal volume 10mL) of the structure that haves three layers.This ampoule 10 has shape shown in Figure 1, and thickness of pipe wall is internal layer 50 μ m, intermediate layer 100 μ m, outer 700 μ m.
The performance evaluation of<plastic ampoule 〉
Filling medicinal liquid to embodiment 10 was implemented autoclaving 40 minutes with plastic ampoule down at 106 ℃, preserved for 2 weeks down at 60 ℃ then, was determined at the content of the vitamin B2 of the vitamin B2 aqueous solution of filling in the ampoule.In addition, vitamin B2 is the medicament of photodegradation.
Measurement result is that the remaining quantity of vitamin B2 after preserving for 2 weeks is more than the 95 weight %, shows that its photodegradation has obviously obtained sufficient inhibition.That is, the ampoule of embodiment 10 prevents that the ability (optics barrier) that light sees through is good.This thinks to have mixed the layer that coloring agent (organic pigment) makes because the ampoule of embodiment 10 has.
And the vitamin B2 aqueous solution has also obviously obtained abundant inhibition to the dissolving of contained pigment in the skin.This thinks because the layer inboard that mixed colorant (organic pigment) makes has poly-cycloolefin layer.
The manufacturing of the plastic ampoule of<filling medicinal liquid 〉
(embodiment 11)
Use has blowing, filling, the sealing machine of 5 layers of blowing mould, by PE1 (polyolefin) preparation internal layer, AD1 (improved polyalkene) preparation intermediate layer (internal layer side), NY1 (polyamide; M-xylene diamine-adipic acid condensation polymer) preparation intermediate layer (pars intermedia), AD1 prepare intermediate layer (outer layer side) and PP2 (ultraviolet isolating plastics) preparation skin, and Palmic acid (acid of パ Le チ ミ Application) the vitamin A solubilize liquid 2mL of 400IU/mL fills in portion within it, makes the filling medicinal liquid plastic ampoule (internal volume 2mL) of the structure that is of five storeys.This ampoule 10 has shape shown in Figure 1, and thickness of pipe wall is internal layer 50 μ m, and intermediate layer (internal layer side and outer layer side) respectively is 10 μ m, and intermediate layer (pars intermedia) is 100 μ m, outer 500 μ m.
The performance evaluation of<plastic ampoule 〉
The filling medicinal liquid of embodiment 11 is implemented autoclaving 40 minutes with plastic ampoule down at 106 ℃, under 60 ℃, 60%RH, preserved for 2 weeks then, be determined at the content of the Palimitate-A of the Palimitate-A solubilize liquid of filling in the ampoule.In addition, Palimitate-A is the medicament of easily oxidizable and photodegradation.
Measurement result is that the remaining quantity of Palimitate-A after preserving for 2 weeks is more than the 95 weight %, shows that its oxidative degradation and photodegradation have obtained sufficient inhibition.That is, the ampoule of embodiment 11 prevents the ability of gas permeation (barrier properties for gases, particularly oxygen barrier performance) and prevents that the ability (light barrier) that light sees through is good.This thinks because the ampoule of embodiment 11 has the layer that aramid layer and mixed colorant (organic pigment) make.
And, show that Palimitate-A solubilize liquid has obtained abundant inhibition to the dissolving of contained pigment in the skin.This thinks because the layer inboard that mixed colorant (organic pigment) makes has aramid layer.
In addition, the layer structure of the plastic ampoule that obtains among the embodiment 7~11 etc. is summarised in the table 2.
<table 2 〉
Above: in the middle of the material: below the mixed proportion of resin (weight ratio): layer thickness
The manufacturing of the plastic ampoule of<filling medicinal liquid 〉
(embodiment 12)
Use has blowing, filling, the sealing machine of 2 layers of blowing mould, prepare skin by COP2 (poly-cycloolefin) preparation internal layer, PE1 (polyolefin), and normal saline 10mL fills in portion, makes the filling medicinal liquid plastic ampoule that 2 layers of structure are arranged within it.This ampoule 18 has 5 disjunctor shapes shown in Figure 2, and thickness of pipe wall is internal layer 200 μ m, outer 500 μ m.
(embodiment 13)
Use has blowing, filling, the sealing machine of 2 layers of blowing mould, and by COP2 (poly-cycloolefin) preparation internal layer, COP3 (poly-cycloolefin) preparation skin, and normal saline 10mL fills in portion within it, makes the filling medicinal liquid plastic ampoule that 2 layers of structure are arranged.This ampoule 18 has 5 disjunctor shapes shown in Figure 2, and thickness of pipe wall is internal layer 200 μ m, outer 500 μ m.
(embodiment 14)
Use has blowing, filling, the sealing machine of 2 layers of blowing mould, prepare skin by COC1 (poly-cycloolefin) preparation internal layer, PE1 (polyolefin), and normal saline 10mL fills in portion, makes the filling medicinal liquid plastic ampoule that 2 layers of structure are arranged within it.This ampoule 18 has 5 disjunctor shapes shown in Figure 2, and thickness of pipe wall is internal layer 200 μ m, outer 500 μ m.
(embodiment 15)
Use has blowing, filling, the sealing machine of 2 layers of blowing mould, and by COC2 (poly-cycloolefin) preparation internal layer, PE1 (poly-cycloolefin) preparation skin, and normal saline 10mL fills in portion within it, makes the filling medicinal liquid plastic ampoule that 2 layers of structure are arranged.This ampoule 18 has 5 disjunctor shapes shown in Figure 2, and thickness of pipe wall is internal layer 200 μ m, outer 500 μ m.
(embodiment 16)
Use has blowing, filling, the sealing machine of 2 layers of blowing mould, prepare skin by COC3 (poly-cycloolefin) preparation internal layer, PE1 (polyolefin), and normal saline 10mL fills in portion, makes the filling medicinal liquid plastic ampoule that 2 layers of structure are arranged within it.This ampoule 18 has 5 disjunctor shapes shown in Figure 2, and thickness of pipe wall is internal layer 200 μ m, outer 500 μ m.
(comparative example 1)
Use blowing, filling, sealing machine, by COP3 (poly-cycloolefin, Tg is 136 ℃) preparation, and normal saline 10mL fills in portion within it, makes the plastic ampoule of single layer structure.This ampoule 18 has 5 disjunctor shapes shown in Figure 2, and thickness of pipe wall is 800 μ m.
(reference example 1)
Use blowing, filling, sealing machine, by COP2 (poly-cycloolefin, Tg is 70 ℃) preparation, and normal saline 10mL fills in portion within it, makes the plastic ampoule 18 of single layer structure.This ampoule 18 has 5 disjunctor shapes shown in Figure 2, and thickness of pipe wall is 800 μ m.
(reference example 2)
Use blowing, filling, sealing machine, by COC1 (poly-cycloolefin, Tg is 105 ℃) preparation, and normal saline 10mL fills in portion within it, makes the plastic ampoule 18 of single layer structure.This ampoule 18 has 5 disjunctor shapes shown in Figure 2, and thickness of pipe wall is 800 μ m.
The performance evaluation of<plastic ampoule 〉
Confirming to have aneroid to leak for the plastic ampoule range estimation that obtains in the foregoing description 12~16, comparative example 1 and the reference example 1~2 takes place.To be poly-cycloolefin and glass transition temperature (Tg) all do not detected liquid at 50 ampoules (ampoules of 10 5 disjunctors) of 110 ℃ or following embodiment 12~16 to the plastics that consequently form internal layer leaks.Relative therewith, 8 one-tenth of 50 ampoules of comparative example 1 is that 40 ampoules have all detected the liquid leakage.
In addition, shown in reference example 1 and 2, plastic ampoule also can be the individual layers that is made by a kind of poly-cyclic olefin in actual use.At this moment, the poly-cycloolefin that forms ampoule integral body preferably uses glass transition temperature at 110 ℃ or following poly-cycloolefin.The glass transition temperature of poly-cycloolefin is preferably 60~105 ℃, more preferably 60~80 ℃.
The layer structure of the plastic ampoule that obtains in embodiment 12~16, comparative example 1 and the reference example 1~2 etc. is summarised in the table 3.
<table 3 〉
Above: below the material (glass transition temperature ℃): layer thickness
As mentioned above, plastic ampoule provided by the invention can be used for aseptic and stably take care of, preserves easy oxidation medicament, photodegradation medicament, absorbs absorption preparation etc., and then applicable to the manufacturing of this plastic ampoule.
Claims (10)
1, a kind of plastic ampoule that is used to fill medicinal liquid, it is characterized in that the plastic ampoule of this filling medicinal liquid has the container body part of flexibility, seal the fused portion of this container body part opening, with be connected in being used on this fused portion and twist off the grip portion of fused portion, the said vesse main part, fused portion and grip portion are to use that the tubular parison is integrally formed to be made, described tubular parison has and contains the innermost layer that is formed by polyolefin, the intermediate layer that forms by polyolefin and poly-cyclic olefin, by polyolefin form outermost more than 3 layers the layer, the said vesse main part is to be shaped with dividing die clamp to live in to state parison, medicinal liquid is filled by portion within it, the closed peristome position makes then, and at least 1 layer of above-mentioned parison is to have to be selected to prevent gas permeation, prevent steam permeable, prevent that light from seeing through, prevent that medicine from seeing through and preventing drug absorption, the functional layer of at least one characteristic of adsorption function.
2, as the plastic ampoule of the filling medicinal liquid of claim 1 record, wherein at least 1 layer except that the innermost layer of above-mentioned parison is to be selected from the layer that at least one medicament of coloring agent, UV absorbent and oxygen absorbent makes by mixing, and than the layer of this layer inside be have prevent medicine see through function layer.
3, as the plastic ampoule of the filling medicinal liquid of claim 1 record, wherein the above-mentioned functions layer contains aramid layer.
4, as the plastic ampoule of the filling medicinal liquid of claim 1 record, wherein the above-mentioned functions layer contains the polyhydric alcohol layer.
5, as the plastic ampoule of the filling medicinal liquid of claim 1 record, wherein the above-mentioned functions layer contains polyester layer.
6, as the plastic ampoule of the filling medicinal liquid of claim 1 record, wherein the above-mentioned functions layer contains poly-cyclic olefin layer.
7, as the plastic ampoule of the filling medicinal liquid of claim 1 record, the connector of a plurality of ampoules that its thinner wall section that can fracture of serving as reasons connects.
8, as the plastic ampoule of the filling medicinal liquid of claim 1 record, wherein the above-mentioned functions layer is to have the layer that can prevent steam permeable and prevent drug absorption, adsorption function, and inner capacities is 0.5~20mL.
9, a kind of manufacture method of filling the plastic ampoule that medicinal liquid uses, it is characterized in that comprising the following steps: that the following die clamp that can divide with the partially-formed usefulness of container body lives the tubular parison, form the cavity in the inside of tubular parison and come the forming containers main part, then, in this container body part, fill medicinal liquid, then use and to divide die clamp to live the opening of this container body part, form the fused portion of this opening of sealing and be connected in being used on this fused portion and twist off the grip portion of fused portion, wherein said tubular parison has and contains the innermost layer that is formed by polyolefin, the intermediate layer that forms by polyolefin and poly-cyclic olefin, by the outermost layer more than 3 layers that polyolefin forms, wherein at least 1 layer is to have to be selected to prevent gas permeation, prevent steam permeable, prevent that light from seeing through, prevent that medicine from seeing through and preventing drug absorption, the functional layer of at least one characteristic of absorption.
10, the manufacture method of the plastic ampoule of using as the filling medicinal liquid of claim 9 record, wherein be to use except that innermost layer, to have at least 1 layer to be the layer that at least one medicament that mixed to be selected from coloring agent, UV absorbent and oxygen absorbent makes as above-mentioned parison, and than the layer of this layer inside be have prevent medicine see through function layer.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003118901 | 2003-04-23 | ||
JP118901/2003 | 2003-04-23 | ||
JP364971/2003 | 2003-10-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1777406A CN1777406A (en) | 2006-05-24 |
CN100515381C true CN100515381C (en) | 2009-07-22 |
Family
ID=36766599
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2004800106848A Expired - Lifetime CN100515381C (en) | 2003-04-23 | 2004-04-19 | Drug solution filling plastic ampoule and production method therefor |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100515381C (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104379069A (en) * | 2012-03-28 | 2015-02-25 | 伊西康内外科公司 | Tissue thickness compensator comprising a reservoir |
Families Citing this family (381)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070084897A1 (en) | 2003-05-20 | 2007-04-19 | Shelton Frederick E Iv | Articulating surgical stapling instrument incorporating a two-piece e-beam firing mechanism |
US9060770B2 (en) | 2003-05-20 | 2015-06-23 | Ethicon Endo-Surgery, Inc. | Robotically-driven surgical instrument with E-beam driver |
US11890012B2 (en) | 2004-07-28 | 2024-02-06 | Cilag Gmbh International | Staple cartridge comprising cartridge body and attached support |
US8215531B2 (en) | 2004-07-28 | 2012-07-10 | Ethicon Endo-Surgery, Inc. | Surgical stapling instrument having a medical substance dispenser |
US11246590B2 (en) | 2005-08-31 | 2022-02-15 | Cilag Gmbh International | Staple cartridge including staple drivers having different unfired heights |
US11484312B2 (en) | 2005-08-31 | 2022-11-01 | Cilag Gmbh International | Staple cartridge comprising a staple driver arrangement |
US10159482B2 (en) | 2005-08-31 | 2018-12-25 | Ethicon Llc | Fastener cartridge assembly comprising a fixed anvil and different staple heights |
US7669746B2 (en) | 2005-08-31 | 2010-03-02 | Ethicon Endo-Surgery, Inc. | Staple cartridges for forming staples having differing formed staple heights |
US9237891B2 (en) | 2005-08-31 | 2016-01-19 | Ethicon Endo-Surgery, Inc. | Robotically-controlled surgical stapling devices that produce formed staples having different lengths |
US7934630B2 (en) | 2005-08-31 | 2011-05-03 | Ethicon Endo-Surgery, Inc. | Staple cartridges for forming staples having differing formed staple heights |
US20070106317A1 (en) | 2005-11-09 | 2007-05-10 | Shelton Frederick E Iv | Hydraulically and electrically actuated articulation joints for surgical instruments |
US11793518B2 (en) | 2006-01-31 | 2023-10-24 | Cilag Gmbh International | Powered surgical instruments with firing system lockout arrangements |
US7845537B2 (en) | 2006-01-31 | 2010-12-07 | Ethicon Endo-Surgery, Inc. | Surgical instrument having recording capabilities |
US11224427B2 (en) | 2006-01-31 | 2022-01-18 | Cilag Gmbh International | Surgical stapling system including a console and retraction assembly |
US20110024477A1 (en) | 2009-02-06 | 2011-02-03 | Hall Steven G | Driven Surgical Stapler Improvements |
US8708213B2 (en) | 2006-01-31 | 2014-04-29 | Ethicon Endo-Surgery, Inc. | Surgical instrument having a feedback system |
US20110290856A1 (en) | 2006-01-31 | 2011-12-01 | Ethicon Endo-Surgery, Inc. | Robotically-controlled surgical instrument with force-feedback capabilities |
US20120292367A1 (en) | 2006-01-31 | 2012-11-22 | Ethicon Endo-Surgery, Inc. | Robotically-controlled end effector |
US7753904B2 (en) | 2006-01-31 | 2010-07-13 | Ethicon Endo-Surgery, Inc. | Endoscopic surgical instrument with a handle that can articulate with respect to the shaft |
US8186555B2 (en) | 2006-01-31 | 2012-05-29 | Ethicon Endo-Surgery, Inc. | Motor-driven surgical cutting and fastening instrument with mechanical closure system |
US11278279B2 (en) | 2006-01-31 | 2022-03-22 | Cilag Gmbh International | Surgical instrument assembly |
US8820603B2 (en) | 2006-01-31 | 2014-09-02 | Ethicon Endo-Surgery, Inc. | Accessing data stored in a memory of a surgical instrument |
US8992422B2 (en) | 2006-03-23 | 2015-03-31 | Ethicon Endo-Surgery, Inc. | Robotically-controlled endoscopic accessory channel |
US8322455B2 (en) | 2006-06-27 | 2012-12-04 | Ethicon Endo-Surgery, Inc. | Manually driven surgical cutting and fastening instrument |
US10568652B2 (en) | 2006-09-29 | 2020-02-25 | Ethicon Llc | Surgical staples having attached drivers of different heights and stapling instruments for deploying the same |
US8652120B2 (en) | 2007-01-10 | 2014-02-18 | Ethicon Endo-Surgery, Inc. | Surgical instrument with wireless communication between control unit and sensor transponders |
US11291441B2 (en) | 2007-01-10 | 2022-04-05 | Cilag Gmbh International | Surgical instrument with wireless communication between control unit and remote sensor |
US8684253B2 (en) | 2007-01-10 | 2014-04-01 | Ethicon Endo-Surgery, Inc. | Surgical instrument with wireless communication between a control unit of a robotic system and remote sensor |
US11039836B2 (en) | 2007-01-11 | 2021-06-22 | Cilag Gmbh International | Staple cartridge for use with a surgical stapling instrument |
US20080169332A1 (en) | 2007-01-11 | 2008-07-17 | Shelton Frederick E | Surgical stapling device with a curved cutting member |
US20090001121A1 (en) | 2007-03-15 | 2009-01-01 | Hess Christopher J | Surgical staple having an expandable portion |
US11672531B2 (en) | 2007-06-04 | 2023-06-13 | Cilag Gmbh International | Rotary drive systems for surgical instruments |
US8931682B2 (en) | 2007-06-04 | 2015-01-13 | Ethicon Endo-Surgery, Inc. | Robotically-controlled shaft based rotary drive systems for surgical instruments |
US7753245B2 (en) | 2007-06-22 | 2010-07-13 | Ethicon Endo-Surgery, Inc. | Surgical stapling instruments |
US11849941B2 (en) | 2007-06-29 | 2023-12-26 | Cilag Gmbh International | Staple cartridge having staple cavities extending at a transverse angle relative to a longitudinal cartridge axis |
US8573465B2 (en) | 2008-02-14 | 2013-11-05 | Ethicon Endo-Surgery, Inc. | Robotically-controlled surgical end effector system with rotary actuated closure systems |
US9179912B2 (en) | 2008-02-14 | 2015-11-10 | Ethicon Endo-Surgery, Inc. | Robotically-controlled motorized surgical cutting and fastening instrument |
US7819298B2 (en) | 2008-02-14 | 2010-10-26 | Ethicon Endo-Surgery, Inc. | Surgical stapling apparatus with control features operable with one hand |
BRPI0901282A2 (en) | 2008-02-14 | 2009-11-17 | Ethicon Endo Surgery Inc | surgical cutting and fixation instrument with rf electrodes |
US8636736B2 (en) | 2008-02-14 | 2014-01-28 | Ethicon Endo-Surgery, Inc. | Motorized surgical cutting and fastening instrument |
US8758391B2 (en) | 2008-02-14 | 2014-06-24 | Ethicon Endo-Surgery, Inc. | Interchangeable tools for surgical instruments |
US7866527B2 (en) | 2008-02-14 | 2011-01-11 | Ethicon Endo-Surgery, Inc. | Surgical stapling apparatus with interlockable firing system |
US10390823B2 (en) | 2008-02-15 | 2019-08-27 | Ethicon Llc | End effector comprising an adjunct |
CN101969913B (en) * | 2008-03-14 | 2013-10-16 | 株式会社大塚制药工厂 | Plastic ampule |
CN102836066B (en) * | 2008-03-14 | 2014-11-05 | 株式会社大塚制药工厂 | Plastic ampoule and colored plastic container |
US8210411B2 (en) | 2008-09-23 | 2012-07-03 | Ethicon Endo-Surgery, Inc. | Motor-driven surgical cutting instrument |
US9005230B2 (en) | 2008-09-23 | 2015-04-14 | Ethicon Endo-Surgery, Inc. | Motorized surgical instrument |
US9386983B2 (en) | 2008-09-23 | 2016-07-12 | Ethicon Endo-Surgery, Llc | Robotically-controlled motorized surgical instrument |
US11648005B2 (en) | 2008-09-23 | 2023-05-16 | Cilag Gmbh International | Robotically-controlled motorized surgical instrument with an end effector |
US8608045B2 (en) | 2008-10-10 | 2013-12-17 | Ethicon Endo-Sugery, Inc. | Powered surgical cutting and stapling apparatus with manually retractable firing system |
US8517239B2 (en) | 2009-02-05 | 2013-08-27 | Ethicon Endo-Surgery, Inc. | Surgical stapling instrument comprising a magnetic element driver |
BRPI1008667A2 (en) | 2009-02-06 | 2016-03-08 | Ethicom Endo Surgery Inc | improvement of the operated surgical stapler |
WO2011039986A1 (en) * | 2009-10-02 | 2011-04-07 | 株式会社細川洋行 | Storing container |
US8851354B2 (en) | 2009-12-24 | 2014-10-07 | Ethicon Endo-Surgery, Inc. | Surgical cutting instrument that analyzes tissue thickness |
US8220688B2 (en) | 2009-12-24 | 2012-07-17 | Ethicon Endo-Surgery, Inc. | Motor-driven surgical cutting instrument with electric actuator directional control assembly |
US8783543B2 (en) | 2010-07-30 | 2014-07-22 | Ethicon Endo-Surgery, Inc. | Tissue acquisition arrangements and methods for surgical stapling devices |
CN102229225A (en) * | 2010-08-27 | 2011-11-02 | 上海海昌医用塑胶厂 | Method for manufacturing anti-dropping COC (cycloolefin copolymer) plastic bottle |
US8864009B2 (en) | 2010-09-30 | 2014-10-21 | Ethicon Endo-Surgery, Inc. | Tissue thickness compensator for a surgical stapler comprising an adjustable anvil |
US9386988B2 (en) | 2010-09-30 | 2016-07-12 | Ethicon End-Surgery, LLC | Retainer assembly including a tissue thickness compensator |
US11812965B2 (en) | 2010-09-30 | 2023-11-14 | Cilag Gmbh International | Layer of material for a surgical end effector |
US11849952B2 (en) | 2010-09-30 | 2023-12-26 | Cilag Gmbh International | Staple cartridge comprising staples positioned within a compressible portion thereof |
US11298125B2 (en) | 2010-09-30 | 2022-04-12 | Cilag Gmbh International | Tissue stapler having a thickness compensator |
US9839420B2 (en) | 2010-09-30 | 2017-12-12 | Ethicon Llc | Tissue thickness compensator comprising at least one medicament |
US10945731B2 (en) | 2010-09-30 | 2021-03-16 | Ethicon Llc | Tissue thickness compensator comprising controlled release and expansion |
US9629814B2 (en) | 2010-09-30 | 2017-04-25 | Ethicon Endo-Surgery, Llc | Tissue thickness compensator configured to redistribute compressive forces |
US9861361B2 (en) | 2010-09-30 | 2018-01-09 | Ethicon Llc | Releasable tissue thickness compensator and fastener cartridge having the same |
US8695866B2 (en) | 2010-10-01 | 2014-04-15 | Ethicon Endo-Surgery, Inc. | Surgical instrument having a power control circuit |
CN103458849A (en) * | 2011-04-06 | 2013-12-18 | 株式会社大塚制药工厂 | Plastic ampule |
JP6026509B2 (en) | 2011-04-29 | 2016-11-16 | エシコン・エンド−サージェリィ・インコーポレイテッドEthicon Endo−Surgery,Inc. | Staple cartridge including staples disposed within a compressible portion of the staple cartridge itself |
CN102274122A (en) * | 2011-05-20 | 2011-12-14 | 海南卫康制药(潜山)有限公司 | Packing bottle suitable for injection medicaments |
US9072535B2 (en) | 2011-05-27 | 2015-07-07 | Ethicon Endo-Surgery, Inc. | Surgical stapling instruments with rotatable staple deployment arrangements |
US11207064B2 (en) | 2011-05-27 | 2021-12-28 | Cilag Gmbh International | Automated end effector component reloading system for use with a robotic system |
DE102011106162B3 (en) * | 2011-06-30 | 2012-09-13 | Sartorius Stedim Biotech Gmbh | Bioreactor containers and bioreactor container integrity testing methods |
CN102249174B (en) * | 2011-07-04 | 2012-11-07 | 楚天科技股份有限公司 | Forming device for plastic ampoule |
US20130018329A1 (en) * | 2011-07-14 | 2013-01-17 | Mehta Ketan C | Portable ampoule with a specialized tip and sealer |
CN102431946B (en) * | 2011-11-17 | 2013-12-04 | 楚天科技股份有限公司 | Plastic ampoule blowing-filing and sealing integrated machine |
CN102515071B (en) * | 2011-11-17 | 2014-01-29 | 楚天科技股份有限公司 | Plastic ampoule blowing, filling and sealing all-in-one machine |
US9044230B2 (en) | 2012-02-13 | 2015-06-02 | Ethicon Endo-Surgery, Inc. | Surgical cutting and fastening instrument with apparatus for determining cartridge and firing motion status |
JP5980700B2 (en) * | 2012-03-19 | 2016-08-31 | 株式会社ポーラファルマ | Resin container filled with antifungal pharmaceutical composition |
MX353040B (en) | 2012-03-28 | 2017-12-18 | Ethicon Endo Surgery Inc | Retainer assembly including a tissue thickness compensator. |
JP6305979B2 (en) | 2012-03-28 | 2018-04-04 | エシコン・エンド−サージェリィ・インコーポレイテッドEthicon Endo−Surgery,Inc. | Tissue thickness compensator with multiple layers |
BR112014024098B1 (en) | 2012-03-28 | 2021-05-25 | Ethicon Endo-Surgery, Inc. | staple cartridge |
US9101358B2 (en) | 2012-06-15 | 2015-08-11 | Ethicon Endo-Surgery, Inc. | Articulatable surgical instrument comprising a firing drive |
US9289256B2 (en) | 2012-06-28 | 2016-03-22 | Ethicon Endo-Surgery, Llc | Surgical end effectors having angled tissue-contacting surfaces |
EP2866686A1 (en) | 2012-06-28 | 2015-05-06 | Ethicon Endo-Surgery, Inc. | Empty clip cartridge lockout |
US11202631B2 (en) | 2012-06-28 | 2021-12-21 | Cilag Gmbh International | Stapling assembly comprising a firing lockout |
US20140001231A1 (en) | 2012-06-28 | 2014-01-02 | Ethicon Endo-Surgery, Inc. | Firing system lockout arrangements for surgical instruments |
BR112014032776B1 (en) | 2012-06-28 | 2021-09-08 | Ethicon Endo-Surgery, Inc | SURGICAL INSTRUMENT SYSTEM AND SURGICAL KIT FOR USE WITH A SURGICAL INSTRUMENT SYSTEM |
US9649111B2 (en) | 2012-06-28 | 2017-05-16 | Ethicon Endo-Surgery, Llc | Replaceable clip cartridge for a clip applier |
US20140001234A1 (en) | 2012-06-28 | 2014-01-02 | Ethicon Endo-Surgery, Inc. | Coupling arrangements for attaching surgical end effectors to drive systems therefor |
BR112015021098B1 (en) | 2013-03-01 | 2022-02-15 | Ethicon Endo-Surgery, Inc | COVERAGE FOR A JOINT JOINT AND SURGICAL INSTRUMENT |
JP6345707B2 (en) | 2013-03-01 | 2018-06-20 | エシコン・エンド−サージェリィ・インコーポレイテッドEthicon Endo−Surgery,Inc. | Surgical instrument with soft stop |
US9808244B2 (en) | 2013-03-14 | 2017-11-07 | Ethicon Llc | Sensor arrangements for absolute positioning system for surgical instruments |
US9629629B2 (en) | 2013-03-14 | 2017-04-25 | Ethicon Endo-Surgey, LLC | Control systems for surgical instruments |
BR112015026109B1 (en) | 2013-04-16 | 2022-02-22 | Ethicon Endo-Surgery, Inc | surgical instrument |
US9867612B2 (en) | 2013-04-16 | 2018-01-16 | Ethicon Llc | Powered surgical stapler |
JP6416260B2 (en) | 2013-08-23 | 2018-10-31 | エシコン エルエルシー | Firing member retractor for a powered surgical instrument |
US9775609B2 (en) | 2013-08-23 | 2017-10-03 | Ethicon Llc | Tamper proof circuit for surgical instrument battery pack |
US9962161B2 (en) | 2014-02-12 | 2018-05-08 | Ethicon Llc | Deliverable surgical instrument |
CN103830274A (en) * | 2014-03-12 | 2014-06-04 | 蒲增军 | Smearing agent for eliminating henpox |
US9820738B2 (en) | 2014-03-26 | 2017-11-21 | Ethicon Llc | Surgical instrument comprising interactive systems |
BR112016021943B1 (en) | 2014-03-26 | 2022-06-14 | Ethicon Endo-Surgery, Llc | SURGICAL INSTRUMENT FOR USE BY AN OPERATOR IN A SURGICAL PROCEDURE |
US9826977B2 (en) | 2014-03-26 | 2017-11-28 | Ethicon Llc | Sterilization verification circuit |
BR112016023807B1 (en) | 2014-04-16 | 2022-07-12 | Ethicon Endo-Surgery, Llc | CARTRIDGE SET OF FASTENERS FOR USE WITH A SURGICAL INSTRUMENT |
US20150297223A1 (en) | 2014-04-16 | 2015-10-22 | Ethicon Endo-Surgery, Inc. | Fastener cartridges including extensions having different configurations |
US10299792B2 (en) | 2014-04-16 | 2019-05-28 | Ethicon Llc | Fastener cartridge comprising non-uniform fasteners |
CN106456158B (en) | 2014-04-16 | 2019-02-05 | 伊西康内外科有限责任公司 | Fastener cartridge including non-uniform fastener |
JP6636452B2 (en) | 2014-04-16 | 2020-01-29 | エシコン エルエルシーEthicon LLC | Fastener cartridge including extension having different configurations |
US9480746B2 (en) | 2014-04-21 | 2016-11-01 | Pola Pharma Inc. | Resin container filled with antifungal pharmaceutical composition |
BR112017004361B1 (en) | 2014-09-05 | 2023-04-11 | Ethicon Llc | ELECTRONIC SYSTEM FOR A SURGICAL INSTRUMENT |
US11311294B2 (en) | 2014-09-05 | 2022-04-26 | Cilag Gmbh International | Powered medical device including measurement of closure state of jaws |
US10016199B2 (en) | 2014-09-05 | 2018-07-10 | Ethicon Llc | Polarity of hall magnet to identify cartridge type |
US10105142B2 (en) | 2014-09-18 | 2018-10-23 | Ethicon Llc | Surgical stapler with plurality of cutting elements |
US11523821B2 (en) | 2014-09-26 | 2022-12-13 | Cilag Gmbh International | Method for creating a flexible staple line |
BR112017005981B1 (en) | 2014-09-26 | 2022-09-06 | Ethicon, Llc | ANCHOR MATERIAL FOR USE WITH A SURGICAL STAPLE CARTRIDGE AND SURGICAL STAPLE CARTRIDGE FOR USE WITH A SURGICAL INSTRUMENT |
EP3202389A4 (en) * | 2014-10-02 | 2018-06-20 | Terumo Kabushiki Kaisha | Medical container for accommodating protein solution preparation therein |
US10076325B2 (en) | 2014-10-13 | 2018-09-18 | Ethicon Llc | Surgical stapling apparatus comprising a tissue stop |
US9924944B2 (en) | 2014-10-16 | 2018-03-27 | Ethicon Llc | Staple cartridge comprising an adjunct material |
US10517594B2 (en) | 2014-10-29 | 2019-12-31 | Ethicon Llc | Cartridge assemblies for surgical staplers |
US11141153B2 (en) | 2014-10-29 | 2021-10-12 | Cilag Gmbh International | Staple cartridges comprising driver arrangements |
US9844376B2 (en) | 2014-11-06 | 2017-12-19 | Ethicon Llc | Staple cartridge comprising a releasable adjunct material |
US10736636B2 (en) | 2014-12-10 | 2020-08-11 | Ethicon Llc | Articulatable surgical instrument system |
US9987000B2 (en) | 2014-12-18 | 2018-06-05 | Ethicon Llc | Surgical instrument assembly comprising a flexible articulation system |
US9943309B2 (en) | 2014-12-18 | 2018-04-17 | Ethicon Llc | Surgical instruments with articulatable end effectors and movable firing beam support arrangements |
BR112017012996B1 (en) | 2014-12-18 | 2022-11-08 | Ethicon Llc | SURGICAL INSTRUMENT WITH AN ANvil WHICH IS SELECTIVELY MOVABLE ABOUT AN IMMOVABLE GEOMETRIC AXIS DIFFERENT FROM A STAPLE CARTRIDGE |
US9844375B2 (en) | 2014-12-18 | 2017-12-19 | Ethicon Llc | Drive arrangements for articulatable surgical instruments |
US10085748B2 (en) | 2014-12-18 | 2018-10-02 | Ethicon Llc | Locking arrangements for detachable shaft assemblies with articulatable surgical end effectors |
US9844374B2 (en) | 2014-12-18 | 2017-12-19 | Ethicon Llc | Surgical instrument systems comprising an articulatable end effector and means for adjusting the firing stroke of a firing member |
US11154301B2 (en) | 2015-02-27 | 2021-10-26 | Cilag Gmbh International | Modular stapling assembly |
US9901342B2 (en) | 2015-03-06 | 2018-02-27 | Ethicon Endo-Surgery, Llc | Signal and power communication system positioned on a rotatable shaft |
US10687806B2 (en) | 2015-03-06 | 2020-06-23 | Ethicon Llc | Adaptive tissue compression techniques to adjust closure rates for multiple tissue types |
US9993248B2 (en) | 2015-03-06 | 2018-06-12 | Ethicon Endo-Surgery, Llc | Smart sensors with local signal processing |
JP2020121162A (en) | 2015-03-06 | 2020-08-13 | エシコン エルエルシーEthicon LLC | Time dependent evaluation of sensor data to determine stability element, creep element and viscoelastic element of measurement |
US10052044B2 (en) | 2015-03-06 | 2018-08-21 | Ethicon Llc | Time dependent evaluation of sensor data to determine stability, creep, and viscoelastic elements of measures |
US10441279B2 (en) | 2015-03-06 | 2019-10-15 | Ethicon Llc | Multiple level thresholds to modify operation of powered surgical instruments |
US10617412B2 (en) | 2015-03-06 | 2020-04-14 | Ethicon Llc | System for detecting the mis-insertion of a staple cartridge into a surgical stapler |
US10245033B2 (en) | 2015-03-06 | 2019-04-02 | Ethicon Llc | Surgical instrument comprising a lockable battery housing |
US10213201B2 (en) | 2015-03-31 | 2019-02-26 | Ethicon Llc | Stapling end effector configured to compensate for an uneven gap between a first jaw and a second jaw |
US11058425B2 (en) | 2015-08-17 | 2021-07-13 | Ethicon Llc | Implantable layers for a surgical instrument |
US10105139B2 (en) | 2015-09-23 | 2018-10-23 | Ethicon Llc | Surgical stapler having downstream current-based motor control |
US10238386B2 (en) | 2015-09-23 | 2019-03-26 | Ethicon Llc | Surgical stapler having motor control based on an electrical parameter related to a motor current |
US10299878B2 (en) | 2015-09-25 | 2019-05-28 | Ethicon Llc | Implantable adjunct systems for determining adjunct skew |
US10980539B2 (en) | 2015-09-30 | 2021-04-20 | Ethicon Llc | Implantable adjunct comprising bonded layers |
US10478188B2 (en) | 2015-09-30 | 2019-11-19 | Ethicon Llc | Implantable layer comprising a constricted configuration |
US10736633B2 (en) | 2015-09-30 | 2020-08-11 | Ethicon Llc | Compressible adjunct with looping members |
US11890015B2 (en) | 2015-09-30 | 2024-02-06 | Cilag Gmbh International | Compressible adjunct with crossing spacer fibers |
US10292704B2 (en) | 2015-12-30 | 2019-05-21 | Ethicon Llc | Mechanisms for compensating for battery pack failure in powered surgical instruments |
US10368865B2 (en) | 2015-12-30 | 2019-08-06 | Ethicon Llc | Mechanisms for compensating for drivetrain failure in powered surgical instruments |
US10265068B2 (en) | 2015-12-30 | 2019-04-23 | Ethicon Llc | Surgical instruments with separable motors and motor control circuits |
US11213293B2 (en) | 2016-02-09 | 2022-01-04 | Cilag Gmbh International | Articulatable surgical instruments with single articulation link arrangements |
BR112018016098B1 (en) | 2016-02-09 | 2023-02-23 | Ethicon Llc | SURGICAL INSTRUMENT |
US10448948B2 (en) | 2016-02-12 | 2019-10-22 | Ethicon Llc | Mechanisms for compensating for drivetrain failure in powered surgical instruments |
US11224426B2 (en) | 2016-02-12 | 2022-01-18 | Cilag Gmbh International | Mechanisms for compensating for drivetrain failure in powered surgical instruments |
US10617413B2 (en) | 2016-04-01 | 2020-04-14 | Ethicon Llc | Closure system arrangements for surgical cutting and stapling devices with separate and distinct firing shafts |
US10335145B2 (en) | 2016-04-15 | 2019-07-02 | Ethicon Llc | Modular surgical instrument with configurable operating mode |
US10492783B2 (en) | 2016-04-15 | 2019-12-03 | Ethicon, Llc | Surgical instrument with improved stop/start control during a firing motion |
US10357247B2 (en) | 2016-04-15 | 2019-07-23 | Ethicon Llc | Surgical instrument with multiple program responses during a firing motion |
US11607239B2 (en) | 2016-04-15 | 2023-03-21 | Cilag Gmbh International | Systems and methods for controlling a surgical stapling and cutting instrument |
US10456137B2 (en) | 2016-04-15 | 2019-10-29 | Ethicon Llc | Staple formation detection mechanisms |
US10426467B2 (en) | 2016-04-15 | 2019-10-01 | Ethicon Llc | Surgical instrument with detection sensors |
US10828028B2 (en) | 2016-04-15 | 2020-11-10 | Ethicon Llc | Surgical instrument with multiple program responses during a firing motion |
US11179150B2 (en) | 2016-04-15 | 2021-11-23 | Cilag Gmbh International | Systems and methods for controlling a surgical stapling and cutting instrument |
US11317917B2 (en) | 2016-04-18 | 2022-05-03 | Cilag Gmbh International | Surgical stapling system comprising a lockable firing assembly |
US10426469B2 (en) | 2016-04-18 | 2019-10-01 | Ethicon Llc | Surgical instrument comprising a primary firing lockout and a secondary firing lockout |
US20170296173A1 (en) | 2016-04-18 | 2017-10-19 | Ethicon Endo-Surgery, Llc | Method for operating a surgical instrument |
CN110087565A (en) | 2016-12-21 | 2019-08-02 | 爱惜康有限责任公司 | Surgical stapling system |
US10835245B2 (en) | 2016-12-21 | 2020-11-17 | Ethicon Llc | Method for attaching a shaft assembly to a surgical instrument and, alternatively, to a surgical robot |
US10758230B2 (en) | 2016-12-21 | 2020-09-01 | Ethicon Llc | Surgical instrument with primary and safety processors |
JP7010956B2 (en) | 2016-12-21 | 2022-01-26 | エシコン エルエルシー | How to staple tissue |
US20180168615A1 (en) | 2016-12-21 | 2018-06-21 | Ethicon Endo-Surgery, Llc | Method of deforming staples from two different types of staple cartridges with the same surgical stapling instrument |
US11419606B2 (en) | 2016-12-21 | 2022-08-23 | Cilag Gmbh International | Shaft assembly comprising a clutch configured to adapt the output of a rotary firing member to two different systems |
US10758229B2 (en) | 2016-12-21 | 2020-09-01 | Ethicon Llc | Surgical instrument comprising improved jaw control |
US10856868B2 (en) | 2016-12-21 | 2020-12-08 | Ethicon Llc | Firing member pin configurations |
US11160551B2 (en) | 2016-12-21 | 2021-11-02 | Cilag Gmbh International | Articulatable surgical stapling instruments |
US20180168619A1 (en) | 2016-12-21 | 2018-06-21 | Ethicon Endo-Surgery, Llc | Surgical stapling systems |
US10568626B2 (en) | 2016-12-21 | 2020-02-25 | Ethicon Llc | Surgical instruments with jaw opening features for increasing a jaw opening distance |
US11134942B2 (en) | 2016-12-21 | 2021-10-05 | Cilag Gmbh International | Surgical stapling instruments and staple-forming anvils |
US10675026B2 (en) | 2016-12-21 | 2020-06-09 | Ethicon Llc | Methods of stapling tissue |
US10667809B2 (en) | 2016-12-21 | 2020-06-02 | Ethicon Llc | Staple cartridge and staple cartridge channel comprising windows defined therein |
US10898186B2 (en) | 2016-12-21 | 2021-01-26 | Ethicon Llc | Staple forming pocket arrangements comprising primary sidewalls and pocket sidewalls |
CN110099619B (en) | 2016-12-21 | 2022-07-15 | 爱惜康有限责任公司 | Lockout device for surgical end effector and replaceable tool assembly |
US10893864B2 (en) | 2016-12-21 | 2021-01-19 | Ethicon | Staple cartridges and arrangements of staples and staple cavities therein |
US10568624B2 (en) | 2016-12-21 | 2020-02-25 | Ethicon Llc | Surgical instruments with jaws that are pivotable about a fixed axis and include separate and distinct closure and firing systems |
US10954023B2 (en) | 2016-12-29 | 2021-03-23 | Tetra Laval Holdings & Finance S.A. | Package for pourable food products and method for moulding a polymeric opening portion |
US11167889B2 (en) | 2017-04-13 | 2021-11-09 | Rohto Pharmaceutical Co., Ltd. | Squeeze bottle |
US11653914B2 (en) | 2017-06-20 | 2023-05-23 | Cilag Gmbh International | Systems and methods for controlling motor velocity of a surgical stapling and cutting instrument according to articulation angle of end effector |
US11517325B2 (en) | 2017-06-20 | 2022-12-06 | Cilag Gmbh International | Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on measured displacement distance traveled over a specified time interval |
US10307170B2 (en) | 2017-06-20 | 2019-06-04 | Ethicon Llc | Method for closed loop control of motor velocity of a surgical stapling and cutting instrument |
US10624633B2 (en) | 2017-06-20 | 2020-04-21 | Ethicon Llc | Systems and methods for controlling motor velocity of a surgical stapling and cutting instrument |
US10779820B2 (en) | 2017-06-20 | 2020-09-22 | Ethicon Llc | Systems and methods for controlling motor speed according to user input for a surgical instrument |
US10881399B2 (en) | 2017-06-20 | 2021-01-05 | Ethicon Llc | Techniques for adaptive control of motor velocity of a surgical stapling and cutting instrument |
US10888321B2 (en) | 2017-06-20 | 2021-01-12 | Ethicon Llc | Systems and methods for controlling velocity of a displacement member of a surgical stapling and cutting instrument |
US10813639B2 (en) | 2017-06-20 | 2020-10-27 | Ethicon Llc | Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on system conditions |
USD879808S1 (en) | 2017-06-20 | 2020-03-31 | Ethicon Llc | Display panel with graphical user interface |
US10881396B2 (en) | 2017-06-20 | 2021-01-05 | Ethicon Llc | Surgical instrument with variable duration trigger arrangement |
USD879809S1 (en) | 2017-06-20 | 2020-03-31 | Ethicon Llc | Display panel with changeable graphical user interface |
US10980537B2 (en) | 2017-06-20 | 2021-04-20 | Ethicon Llc | Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on measured time over a specified number of shaft rotations |
US10646220B2 (en) | 2017-06-20 | 2020-05-12 | Ethicon Llc | Systems and methods for controlling displacement member velocity for a surgical instrument |
US11071554B2 (en) | 2017-06-20 | 2021-07-27 | Cilag Gmbh International | Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on magnitude of velocity error measurements |
US11382638B2 (en) | 2017-06-20 | 2022-07-12 | Cilag Gmbh International | Closed loop feedback control of motor velocity of a surgical stapling and cutting instrument based on measured time over a specified displacement distance |
USD890784S1 (en) | 2017-06-20 | 2020-07-21 | Ethicon Llc | Display panel with changeable graphical user interface |
US11090046B2 (en) | 2017-06-20 | 2021-08-17 | Cilag Gmbh International | Systems and methods for controlling displacement member motion of a surgical stapling and cutting instrument |
US10856869B2 (en) | 2017-06-27 | 2020-12-08 | Ethicon Llc | Surgical anvil arrangements |
US11141154B2 (en) | 2017-06-27 | 2021-10-12 | Cilag Gmbh International | Surgical end effectors and anvils |
US11324503B2 (en) | 2017-06-27 | 2022-05-10 | Cilag Gmbh International | Surgical firing member arrangements |
US10772629B2 (en) | 2017-06-27 | 2020-09-15 | Ethicon Llc | Surgical anvil arrangements |
US11266405B2 (en) | 2017-06-27 | 2022-03-08 | Cilag Gmbh International | Surgical anvil manufacturing methods |
US10993716B2 (en) | 2017-06-27 | 2021-05-04 | Ethicon Llc | Surgical anvil arrangements |
USD906355S1 (en) | 2017-06-28 | 2020-12-29 | Ethicon Llc | Display screen or portion thereof with a graphical user interface for a surgical instrument |
US10903685B2 (en) | 2017-06-28 | 2021-01-26 | Ethicon Llc | Surgical shaft assemblies with slip ring assemblies forming capacitive channels |
US11058424B2 (en) | 2017-06-28 | 2021-07-13 | Cilag Gmbh International | Surgical instrument comprising an offset articulation joint |
EP4070740A1 (en) | 2017-06-28 | 2022-10-12 | Cilag GmbH International | Surgical instrument comprising selectively actuatable rotatable couplers |
US10716614B2 (en) | 2017-06-28 | 2020-07-21 | Ethicon Llc | Surgical shaft assemblies with slip ring assemblies with increased contact pressure |
US10765427B2 (en) | 2017-06-28 | 2020-09-08 | Ethicon Llc | Method for articulating a surgical instrument |
US10588633B2 (en) | 2017-06-28 | 2020-03-17 | Ethicon Llc | Surgical instruments with open and closable jaws and axially movable firing member that is initially parked in close proximity to the jaws prior to firing |
US11564686B2 (en) | 2017-06-28 | 2023-01-31 | Cilag Gmbh International | Surgical shaft assemblies with flexible interfaces |
US11259805B2 (en) | 2017-06-28 | 2022-03-01 | Cilag Gmbh International | Surgical instrument comprising firing member supports |
US11246592B2 (en) | 2017-06-28 | 2022-02-15 | Cilag Gmbh International | Surgical instrument comprising an articulation system lockable to a frame |
US10898183B2 (en) | 2017-06-29 | 2021-01-26 | Ethicon Llc | Robotic surgical instrument with closed loop feedback techniques for advancement of closure member during firing |
US10932772B2 (en) | 2017-06-29 | 2021-03-02 | Ethicon Llc | Methods for closed loop velocity control for robotic surgical instrument |
US11007022B2 (en) | 2017-06-29 | 2021-05-18 | Ethicon Llc | Closed loop velocity control techniques based on sensed tissue parameters for robotic surgical instrument |
US11944300B2 (en) | 2017-08-03 | 2024-04-02 | Cilag Gmbh International | Method for operating a surgical system bailout |
US11304695B2 (en) | 2017-08-03 | 2022-04-19 | Cilag Gmbh International | Surgical system shaft interconnection |
US11471155B2 (en) | 2017-08-03 | 2022-10-18 | Cilag Gmbh International | Surgical system bailout |
US10765429B2 (en) | 2017-09-29 | 2020-09-08 | Ethicon Llc | Systems and methods for providing alerts according to the operational state of a surgical instrument |
USD907647S1 (en) | 2017-09-29 | 2021-01-12 | Ethicon Llc | Display screen or portion thereof with animated graphical user interface |
USD917500S1 (en) | 2017-09-29 | 2021-04-27 | Ethicon Llc | Display screen or portion thereof with graphical user interface |
USD907648S1 (en) | 2017-09-29 | 2021-01-12 | Ethicon Llc | Display screen or portion thereof with animated graphical user interface |
US11399829B2 (en) | 2017-09-29 | 2022-08-02 | Cilag Gmbh International | Systems and methods of initiating a power shutdown mode for a surgical instrument |
US10743872B2 (en) | 2017-09-29 | 2020-08-18 | Ethicon Llc | System and methods for controlling a display of a surgical instrument |
US11090075B2 (en) | 2017-10-30 | 2021-08-17 | Cilag Gmbh International | Articulation features for surgical end effector |
US11134944B2 (en) | 2017-10-30 | 2021-10-05 | Cilag Gmbh International | Surgical stapler knife motion controls |
US10842490B2 (en) | 2017-10-31 | 2020-11-24 | Ethicon Llc | Cartridge body design with force reduction based on firing completion |
US10779903B2 (en) | 2017-10-31 | 2020-09-22 | Ethicon Llc | Positive shaft rotation lock activated by jaw closure |
US10828033B2 (en) | 2017-12-15 | 2020-11-10 | Ethicon Llc | Handheld electromechanical surgical instruments with improved motor control arrangements for positioning components of an adapter coupled thereto |
US11197670B2 (en) | 2017-12-15 | 2021-12-14 | Cilag Gmbh International | Surgical end effectors with pivotal jaws configured to touch at their respective distal ends when fully closed |
US10869666B2 (en) | 2017-12-15 | 2020-12-22 | Ethicon Llc | Adapters with control systems for controlling multiple motors of an electromechanical surgical instrument |
US11033267B2 (en) | 2017-12-15 | 2021-06-15 | Ethicon Llc | Systems and methods of controlling a clamping member firing rate of a surgical instrument |
US10743874B2 (en) | 2017-12-15 | 2020-08-18 | Ethicon Llc | Sealed adapters for use with electromechanical surgical instruments |
US10687813B2 (en) | 2017-12-15 | 2020-06-23 | Ethicon Llc | Adapters with firing stroke sensing arrangements for use in connection with electromechanical surgical instruments |
US10743875B2 (en) | 2017-12-15 | 2020-08-18 | Ethicon Llc | Surgical end effectors with jaw stiffener arrangements configured to permit monitoring of firing member |
US10779825B2 (en) | 2017-12-15 | 2020-09-22 | Ethicon Llc | Adapters with end effector position sensing and control arrangements for use in connection with electromechanical surgical instruments |
US11071543B2 (en) | 2017-12-15 | 2021-07-27 | Cilag Gmbh International | Surgical end effectors with clamping assemblies configured to increase jaw aperture ranges |
US10779826B2 (en) | 2017-12-15 | 2020-09-22 | Ethicon Llc | Methods of operating surgical end effectors |
US11006955B2 (en) | 2017-12-15 | 2021-05-18 | Ethicon Llc | End effectors with positive jaw opening features for use with adapters for electromechanical surgical instruments |
US10966718B2 (en) | 2017-12-15 | 2021-04-06 | Ethicon Llc | Dynamic clamping assemblies with improved wear characteristics for use in connection with electromechanical surgical instruments |
US10716565B2 (en) | 2017-12-19 | 2020-07-21 | Ethicon Llc | Surgical instruments with dual articulation drivers |
US10729509B2 (en) | 2017-12-19 | 2020-08-04 | Ethicon Llc | Surgical instrument comprising closure and firing locking mechanism |
US11020112B2 (en) | 2017-12-19 | 2021-06-01 | Ethicon Llc | Surgical tools configured for interchangeable use with different controller interfaces |
US11045270B2 (en) | 2017-12-19 | 2021-06-29 | Cilag Gmbh International | Robotic attachment comprising exterior drive actuator |
US10835330B2 (en) | 2017-12-19 | 2020-11-17 | Ethicon Llc | Method for determining the position of a rotatable jaw of a surgical instrument attachment assembly |
USD910847S1 (en) | 2017-12-19 | 2021-02-16 | Ethicon Llc | Surgical instrument assembly |
US11311290B2 (en) | 2017-12-21 | 2022-04-26 | Cilag Gmbh International | Surgical instrument comprising an end effector dampener |
US11129680B2 (en) | 2017-12-21 | 2021-09-28 | Cilag Gmbh International | Surgical instrument comprising a projector |
US11583274B2 (en) | 2017-12-21 | 2023-02-21 | Cilag Gmbh International | Self-guiding stapling instrument |
US11076853B2 (en) | 2017-12-21 | 2021-08-03 | Cilag Gmbh International | Systems and methods of displaying a knife position during transection for a surgical instrument |
CN108785077A (en) * | 2018-05-31 | 2018-11-13 | 湖北科伦药业有限公司 | A kind of Ribavirin ampoule bottle and its production technology |
USD914878S1 (en) | 2018-08-20 | 2021-03-30 | Ethicon Llc | Surgical instrument anvil |
US10912559B2 (en) | 2018-08-20 | 2021-02-09 | Ethicon Llc | Reinforced deformable anvil tip for surgical stapler anvil |
US10842492B2 (en) | 2018-08-20 | 2020-11-24 | Ethicon Llc | Powered articulatable surgical instruments with clutching and locking arrangements for linking an articulation drive system to a firing drive system |
US10856870B2 (en) | 2018-08-20 | 2020-12-08 | Ethicon Llc | Switching arrangements for motor powered articulatable surgical instruments |
US11045192B2 (en) | 2018-08-20 | 2021-06-29 | Cilag Gmbh International | Fabricating techniques for surgical stapler anvils |
US11324501B2 (en) | 2018-08-20 | 2022-05-10 | Cilag Gmbh International | Surgical stapling devices with improved closure members |
US10779821B2 (en) | 2018-08-20 | 2020-09-22 | Ethicon Llc | Surgical stapler anvils with tissue stop features configured to avoid tissue pinch |
US11253256B2 (en) | 2018-08-20 | 2022-02-22 | Cilag Gmbh International | Articulatable motor powered surgical instruments with dedicated articulation motor arrangements |
US11083458B2 (en) | 2018-08-20 | 2021-08-10 | Cilag Gmbh International | Powered surgical instruments with clutching arrangements to convert linear drive motions to rotary drive motions |
US11291440B2 (en) | 2018-08-20 | 2022-04-05 | Cilag Gmbh International | Method for operating a powered articulatable surgical instrument |
US11039834B2 (en) | 2018-08-20 | 2021-06-22 | Cilag Gmbh International | Surgical stapler anvils with staple directing protrusions and tissue stability features |
US11207065B2 (en) | 2018-08-20 | 2021-12-28 | Cilag Gmbh International | Method for fabricating surgical stapler anvils |
CN113302133A (en) * | 2018-12-07 | 2021-08-24 | 藤森工业株式会社 | Eye drop container |
US11147551B2 (en) | 2019-03-25 | 2021-10-19 | Cilag Gmbh International | Firing drive arrangements for surgical systems |
US11147553B2 (en) | 2019-03-25 | 2021-10-19 | Cilag Gmbh International | Firing drive arrangements for surgical systems |
US11696761B2 (en) | 2019-03-25 | 2023-07-11 | Cilag Gmbh International | Firing drive arrangements for surgical systems |
US11172929B2 (en) | 2019-03-25 | 2021-11-16 | Cilag Gmbh International | Articulation drive arrangements for surgical systems |
US11903581B2 (en) | 2019-04-30 | 2024-02-20 | Cilag Gmbh International | Methods for stapling tissue using a surgical instrument |
US11648009B2 (en) | 2019-04-30 | 2023-05-16 | Cilag Gmbh International | Rotatable jaw tip for a surgical instrument |
US11426251B2 (en) | 2019-04-30 | 2022-08-30 | Cilag Gmbh International | Articulation directional lights on a surgical instrument |
US11471157B2 (en) | 2019-04-30 | 2022-10-18 | Cilag Gmbh International | Articulation control mapping for a surgical instrument |
US11432816B2 (en) | 2019-04-30 | 2022-09-06 | Cilag Gmbh International | Articulation pin for a surgical instrument |
US11253254B2 (en) | 2019-04-30 | 2022-02-22 | Cilag Gmbh International | Shaft rotation actuator on a surgical instrument |
US11452528B2 (en) | 2019-04-30 | 2022-09-27 | Cilag Gmbh International | Articulation actuators for a surgical instrument |
US11464601B2 (en) | 2019-06-28 | 2022-10-11 | Cilag Gmbh International | Surgical instrument comprising an RFID system for tracking a movable component |
US11051807B2 (en) | 2019-06-28 | 2021-07-06 | Cilag Gmbh International | Packaging assembly including a particulate trap |
US11553971B2 (en) | 2019-06-28 | 2023-01-17 | Cilag Gmbh International | Surgical RFID assemblies for display and communication |
US11627959B2 (en) | 2019-06-28 | 2023-04-18 | Cilag Gmbh International | Surgical instruments including manual and powered system lockouts |
US11684434B2 (en) | 2019-06-28 | 2023-06-27 | Cilag Gmbh International | Surgical RFID assemblies for instrument operational setting control |
US11478241B2 (en) | 2019-06-28 | 2022-10-25 | Cilag Gmbh International | Staple cartridge including projections |
US11224497B2 (en) | 2019-06-28 | 2022-01-18 | Cilag Gmbh International | Surgical systems with multiple RFID tags |
US11426167B2 (en) | 2019-06-28 | 2022-08-30 | Cilag Gmbh International | Mechanisms for proper anvil attachment surgical stapling head assembly |
US11638587B2 (en) | 2019-06-28 | 2023-05-02 | Cilag Gmbh International | RFID identification systems for surgical instruments |
US11219455B2 (en) | 2019-06-28 | 2022-01-11 | Cilag Gmbh International | Surgical instrument including a lockout key |
US11298132B2 (en) | 2019-06-28 | 2022-04-12 | Cilag GmbH Inlernational | Staple cartridge including a honeycomb extension |
US11497492B2 (en) | 2019-06-28 | 2022-11-15 | Cilag Gmbh International | Surgical instrument including an articulation lock |
US11660163B2 (en) | 2019-06-28 | 2023-05-30 | Cilag Gmbh International | Surgical system with RFID tags for updating motor assembly parameters |
US11291451B2 (en) | 2019-06-28 | 2022-04-05 | Cilag Gmbh International | Surgical instrument with battery compatibility verification functionality |
US11298127B2 (en) | 2019-06-28 | 2022-04-12 | Cilag GmbH Interational | Surgical stapling system having a lockout mechanism for an incompatible cartridge |
US11241235B2 (en) | 2019-06-28 | 2022-02-08 | Cilag Gmbh International | Method of using multiple RFID chips with a surgical assembly |
US11523822B2 (en) | 2019-06-28 | 2022-12-13 | Cilag Gmbh International | Battery pack including a circuit interrupter |
US11246678B2 (en) | 2019-06-28 | 2022-02-15 | Cilag Gmbh International | Surgical stapling system having a frangible RFID tag |
US11376098B2 (en) | 2019-06-28 | 2022-07-05 | Cilag Gmbh International | Surgical instrument system comprising an RFID system |
US11771419B2 (en) | 2019-06-28 | 2023-10-03 | Cilag Gmbh International | Packaging for a replaceable component of a surgical stapling system |
US11259803B2 (en) | 2019-06-28 | 2022-03-01 | Cilag Gmbh International | Surgical stapling system having an information encryption protocol |
US11399837B2 (en) | 2019-06-28 | 2022-08-02 | Cilag Gmbh International | Mechanisms for motor control adjustments of a motorized surgical instrument |
US11607219B2 (en) | 2019-12-19 | 2023-03-21 | Cilag Gmbh International | Staple cartridge comprising a detachable tissue cutting knife |
US11844520B2 (en) | 2019-12-19 | 2023-12-19 | Cilag Gmbh International | Staple cartridge comprising driver retention members |
US11291447B2 (en) | 2019-12-19 | 2022-04-05 | Cilag Gmbh International | Stapling instrument comprising independent jaw closing and staple firing systems |
US11234698B2 (en) | 2019-12-19 | 2022-02-01 | Cilag Gmbh International | Stapling system comprising a clamp lockout and a firing lockout |
US11504122B2 (en) | 2019-12-19 | 2022-11-22 | Cilag Gmbh International | Surgical instrument comprising a nested firing member |
US11304696B2 (en) | 2019-12-19 | 2022-04-19 | Cilag Gmbh International | Surgical instrument comprising a powered articulation system |
US11559304B2 (en) | 2019-12-19 | 2023-01-24 | Cilag Gmbh International | Surgical instrument comprising a rapid closure mechanism |
US11529139B2 (en) | 2019-12-19 | 2022-12-20 | Cilag Gmbh International | Motor driven surgical instrument |
US11701111B2 (en) | 2019-12-19 | 2023-07-18 | Cilag Gmbh International | Method for operating a surgical stapling instrument |
US11576672B2 (en) | 2019-12-19 | 2023-02-14 | Cilag Gmbh International | Surgical instrument comprising a closure system including a closure member and an opening member driven by a drive screw |
US11911032B2 (en) | 2019-12-19 | 2024-02-27 | Cilag Gmbh International | Staple cartridge comprising a seating cam |
US11446029B2 (en) | 2019-12-19 | 2022-09-20 | Cilag Gmbh International | Staple cartridge comprising projections extending from a curved deck surface |
US11529137B2 (en) | 2019-12-19 | 2022-12-20 | Cilag Gmbh International | Staple cartridge comprising driver retention members |
US11464512B2 (en) | 2019-12-19 | 2022-10-11 | Cilag Gmbh International | Staple cartridge comprising a curved deck surface |
US11931033B2 (en) | 2019-12-19 | 2024-03-19 | Cilag Gmbh International | Staple cartridge comprising a latch lockout |
USD966512S1 (en) | 2020-06-02 | 2022-10-11 | Cilag Gmbh International | Staple cartridge |
USD975851S1 (en) | 2020-06-02 | 2023-01-17 | Cilag Gmbh International | Staple cartridge |
USD975850S1 (en) | 2020-06-02 | 2023-01-17 | Cilag Gmbh International | Staple cartridge |
USD975278S1 (en) | 2020-06-02 | 2023-01-10 | Cilag Gmbh International | Staple cartridge |
USD967421S1 (en) | 2020-06-02 | 2022-10-18 | Cilag Gmbh International | Staple cartridge |
USD974560S1 (en) | 2020-06-02 | 2023-01-03 | Cilag Gmbh International | Staple cartridge |
USD976401S1 (en) | 2020-06-02 | 2023-01-24 | Cilag Gmbh International | Staple cartridge |
US20220031320A1 (en) | 2020-07-28 | 2022-02-03 | Cilag Gmbh International | Surgical instruments with flexible firing member actuator constraint arrangements |
US11844518B2 (en) | 2020-10-29 | 2023-12-19 | Cilag Gmbh International | Method for operating a surgical instrument |
USD1013170S1 (en) | 2020-10-29 | 2024-01-30 | Cilag Gmbh International | Surgical instrument assembly |
US11931025B2 (en) | 2020-10-29 | 2024-03-19 | Cilag Gmbh International | Surgical instrument comprising a releasable closure drive lock |
US11452526B2 (en) | 2020-10-29 | 2022-09-27 | Cilag Gmbh International | Surgical instrument comprising a staged voltage regulation start-up system |
US11717289B2 (en) | 2020-10-29 | 2023-08-08 | Cilag Gmbh International | Surgical instrument comprising an indicator which indicates that an articulation drive is actuatable |
US11779330B2 (en) | 2020-10-29 | 2023-10-10 | Cilag Gmbh International | Surgical instrument comprising a jaw alignment system |
US11896217B2 (en) | 2020-10-29 | 2024-02-13 | Cilag Gmbh International | Surgical instrument comprising an articulation lock |
US11517390B2 (en) | 2020-10-29 | 2022-12-06 | Cilag Gmbh International | Surgical instrument comprising a limited travel switch |
US11617577B2 (en) | 2020-10-29 | 2023-04-04 | Cilag Gmbh International | Surgical instrument comprising a sensor configured to sense whether an articulation drive of the surgical instrument is actuatable |
USD980425S1 (en) | 2020-10-29 | 2023-03-07 | Cilag Gmbh International | Surgical instrument assembly |
US11534259B2 (en) | 2020-10-29 | 2022-12-27 | Cilag Gmbh International | Surgical instrument comprising an articulation indicator |
US11678882B2 (en) | 2020-12-02 | 2023-06-20 | Cilag Gmbh International | Surgical instruments with interactive features to remedy incidental sled movements |
US11627960B2 (en) | 2020-12-02 | 2023-04-18 | Cilag Gmbh International | Powered surgical instruments with smart reload with separately attachable exteriorly mounted wiring connections |
US11744581B2 (en) | 2020-12-02 | 2023-09-05 | Cilag Gmbh International | Powered surgical instruments with multi-phase tissue treatment |
US11944296B2 (en) | 2020-12-02 | 2024-04-02 | Cilag Gmbh International | Powered surgical instruments with external connectors |
US11849943B2 (en) | 2020-12-02 | 2023-12-26 | Cilag Gmbh International | Surgical instrument with cartridge release mechanisms |
US11653915B2 (en) | 2020-12-02 | 2023-05-23 | Cilag Gmbh International | Surgical instruments with sled location detection and adjustment features |
US11653920B2 (en) | 2020-12-02 | 2023-05-23 | Cilag Gmbh International | Powered surgical instruments with communication interfaces through sterile barrier |
US11890010B2 (en) | 2020-12-02 | 2024-02-06 | Cllag GmbH International | Dual-sided reinforced reload for surgical instruments |
US11737751B2 (en) | 2020-12-02 | 2023-08-29 | Cilag Gmbh International | Devices and methods of managing energy dissipated within sterile barriers of surgical instrument housings |
US11950777B2 (en) | 2021-02-26 | 2024-04-09 | Cilag Gmbh International | Staple cartridge comprising an information access control system |
US11751869B2 (en) | 2021-02-26 | 2023-09-12 | Cilag Gmbh International | Monitoring of multiple sensors over time to detect moving characteristics of tissue |
US11701113B2 (en) | 2021-02-26 | 2023-07-18 | Cilag Gmbh International | Stapling instrument comprising a separate power antenna and a data transfer antenna |
US11723657B2 (en) | 2021-02-26 | 2023-08-15 | Cilag Gmbh International | Adjustable communication based on available bandwidth and power capacity |
US11696757B2 (en) | 2021-02-26 | 2023-07-11 | Cilag Gmbh International | Monitoring of internal systems to detect and track cartridge motion status |
US11950779B2 (en) | 2021-02-26 | 2024-04-09 | Cilag Gmbh International | Method of powering and communicating with a staple cartridge |
US11749877B2 (en) | 2021-02-26 | 2023-09-05 | Cilag Gmbh International | Stapling instrument comprising a signal antenna |
US11812964B2 (en) | 2021-02-26 | 2023-11-14 | Cilag Gmbh International | Staple cartridge comprising a power management circuit |
US11744583B2 (en) | 2021-02-26 | 2023-09-05 | Cilag Gmbh International | Distal communication array to tune frequency of RF systems |
US11925349B2 (en) | 2021-02-26 | 2024-03-12 | Cilag Gmbh International | Adjustment to transfer parameters to improve available power |
US11730473B2 (en) | 2021-02-26 | 2023-08-22 | Cilag Gmbh International | Monitoring of manufacturing life-cycle |
US11793514B2 (en) | 2021-02-26 | 2023-10-24 | Cilag Gmbh International | Staple cartridge comprising sensor array which may be embedded in cartridge body |
US11723658B2 (en) | 2021-03-22 | 2023-08-15 | Cilag Gmbh International | Staple cartridge comprising a firing lockout |
US11826042B2 (en) | 2021-03-22 | 2023-11-28 | Cilag Gmbh International | Surgical instrument comprising a firing drive including a selectable leverage mechanism |
US11717291B2 (en) | 2021-03-22 | 2023-08-08 | Cilag Gmbh International | Staple cartridge comprising staples configured to apply different tissue compression |
US11759202B2 (en) | 2021-03-22 | 2023-09-19 | Cilag Gmbh International | Staple cartridge comprising an implantable layer |
US11826012B2 (en) | 2021-03-22 | 2023-11-28 | Cilag Gmbh International | Stapling instrument comprising a pulsed motor-driven firing rack |
US11737749B2 (en) | 2021-03-22 | 2023-08-29 | Cilag Gmbh International | Surgical stapling instrument comprising a retraction system |
US11806011B2 (en) | 2021-03-22 | 2023-11-07 | Cilag Gmbh International | Stapling instrument comprising tissue compression systems |
US11832816B2 (en) | 2021-03-24 | 2023-12-05 | Cilag Gmbh International | Surgical stapling assembly comprising nonplanar staples and planar staples |
US11849945B2 (en) | 2021-03-24 | 2023-12-26 | Cilag Gmbh International | Rotary-driven surgical stapling assembly comprising eccentrically driven firing member |
US11857183B2 (en) | 2021-03-24 | 2024-01-02 | Cilag Gmbh International | Stapling assembly components having metal substrates and plastic bodies |
US11896218B2 (en) | 2021-03-24 | 2024-02-13 | Cilag Gmbh International | Method of using a powered stapling device |
US11786239B2 (en) | 2021-03-24 | 2023-10-17 | Cilag Gmbh International | Surgical instrument articulation joint arrangements comprising multiple moving linkage features |
US11944336B2 (en) | 2021-03-24 | 2024-04-02 | Cilag Gmbh International | Joint arrangements for multi-planar alignment and support of operational drive shafts in articulatable surgical instruments |
US11849944B2 (en) | 2021-03-24 | 2023-12-26 | Cilag Gmbh International | Drivers for fastener cartridge assemblies having rotary drive screws |
US11896219B2 (en) | 2021-03-24 | 2024-02-13 | Cilag Gmbh International | Mating features between drivers and underside of a cartridge deck |
US11786243B2 (en) | 2021-03-24 | 2023-10-17 | Cilag Gmbh International | Firing members having flexible portions for adapting to a load during a surgical firing stroke |
US11903582B2 (en) | 2021-03-24 | 2024-02-20 | Cilag Gmbh International | Leveraging surfaces for cartridge installation |
US11744603B2 (en) | 2021-03-24 | 2023-09-05 | Cilag Gmbh International | Multi-axis pivot joints for surgical instruments and methods for manufacturing same |
US11793516B2 (en) | 2021-03-24 | 2023-10-24 | Cilag Gmbh International | Surgical staple cartridge comprising longitudinal support beam |
US11826047B2 (en) | 2021-05-28 | 2023-11-28 | Cilag Gmbh International | Stapling instrument comprising jaw mounts |
US11957337B2 (en) | 2021-10-18 | 2024-04-16 | Cilag Gmbh International | Surgical stapling assembly with offset ramped drive surfaces |
US11877745B2 (en) | 2021-10-18 | 2024-01-23 | Cilag Gmbh International | Surgical stapling assembly having longitudinally-repeating staple leg clusters |
US11937816B2 (en) | 2021-10-28 | 2024-03-26 | Cilag Gmbh International | Electrical lead arrangements for surgical instruments |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN2518505Y (en) * | 2002-02-05 | 2002-10-30 | 张俊杰 | Eye drops bottle |
-
2004
- 2004-04-19 CN CNB2004800106848A patent/CN100515381C/en not_active Expired - Lifetime
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN2518505Y (en) * | 2002-02-05 | 2002-10-30 | 张俊杰 | Eye drops bottle |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104379069A (en) * | 2012-03-28 | 2015-02-25 | 伊西康内外科公司 | Tissue thickness compensator comprising a reservoir |
Also Published As
Publication number | Publication date |
---|---|
CN1777406A (en) | 2006-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100515381C (en) | Drug solution filling plastic ampoule and production method therefor | |
JP4939054B2 (en) | Chemical ampule filled plastic ampule and manufacturing method thereof | |
CA2930072C (en) | Multi-layered plastic polymeric container for the storage of pharmaceutical compositions | |
CN105228923B (en) | Anti-dazzling screen and container | |
ES2535721T3 (en) | EVOH barrier film with reduced autoclave shock | |
AU2007363011B2 (en) | Multilayered body for medical containers and medical container | |
CN101969913A (en) | Plastic ampule and colored plastic container | |
JP7460679B2 (en) | Plastic container for liquid medicine | |
JP5078594B2 (en) | Colored plastic containers | |
JP7240374B2 (en) | plastic container | |
US20070160788A1 (en) | Multilayer container with barrier protection | |
JP4316718B2 (en) | Infusion container | |
JP5382986B2 (en) | Heparin injection solution | |
JP4457580B2 (en) | Infusion container stopper and infusion container equipped with the stopper | |
JP2018192139A (en) | Medical liquid storage plastic container | |
JP2019030588A (en) | Tube port and transfusion bag with port member | |
US20070166493A1 (en) | Barrier container structure and method of production |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |